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 Preface 
 
Introduction 
The two projects that form this portfolio were undertaken between August 2005 and June 2006. 
The first project involved analysing data from a laboratory experiment that was carried out by Dr 
Andrew Richards, a Masters of Surgery student at the University of Sydney. Dr Richards 
conducted a randomised controlled trial to investigate the effect of non-steroidal anti-
inflammatories (NSAIDs) on prostate cancer tumour growth. The trial was carried out on 73 mice 
and the size of the tumours was measured on a regular basis. Dr Richards wished to determine 
whether the use of NSAIDs would slow the growth of these tumours. 
 
The second project was conducted in collaboration with researchers at the School of Public 
Health and the George Institute. Dr Mike Jones and Dr Paul Roderick were initially interested in 
examining the relationship between socioeconomic status and chronic kidney disease using the 
data collected by the National Health and Nutrition Survey (NHANES) in the USA. These data 
are publicly available. Researchers at the George Institute became interested in the analysis 
proposed by Dr Jones and Dr Roderick and offered to provide access to datasets from surveys 
carried out in Thailand and Australia. The collaboration evolved into a study to examine the 
association between socio-economic status and chronic kidney disease and whether this 
association is different in different ethnic groups. 
 
Student’s role 
My role in each was to prepare the data for analysis, provide advice on how the data could be 
analysed, implement the agreed analysis plan and report and provide interpretation of the final 
results. Although my role was the same in both projects my experience was quite different in the 
two projects. In the analysis of the prostate cancer data I was the sole person advising Dr 
Richards. This involved a great deal of responsibility, but also freedom on how the analysis could 
be approached. However, being the sole advisor meant that I had no-one directly involved in the 
project with whom I could discuss the more technical statistical aspects of the project. In such 
instances Dr Timothy Dobbins provided invaluable support and advice. 
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 The analysis of the kidney data, in contrast, involved collaborating with six other researchers. 
These researchers came from diverse clinical, statistical and epidemiological backgrounds and 
brought to the project a wealth of knowledge on the subject and many ideas as to how such data 
could be analysed. The final analysis plan was developed in consultation with Dr Mike Jones with 
input from the other researchers. This entailed less responsibility on my part in determining the 
“correct” analysis, however there was a greater pressure on myself to provide clear and concise 
summaries of the analysis that I performed. 
 
Reflections on learning 
The WPP reinforced for me how little time in a statistical analysis is actually spent producing 
statistical results. The majority of time is taken up by managing and cleaning data, determining 
the correct methods by which to use the data for the current problem and finally interpreting the 
results in the final report. The production of results achieved through the implementation of 
statistical software is in comparison a minor task. However, to ensure that this project produces 
results which are meaningful, effort must be spent on the comparatively mundane task of data 
management, the more abstract conceptualisation of the problem and the more literal 
communication of results. The coursework for the Masters program tended to focus more on the 
narrow implementation of a particular data analysis technique, whereas the WPP has helped me 
to broaden my skills to incorporate the whole process of statistical consultation and analysis. 
 
One of the most important roles of the statistician is to communicate the final results. The 
statistician must do this in a clear, concise way and avoid over-interpreting the results and my 
experience of the WPP certainly improved my communication skills. In particular, for the kidney 
study I regularly presented results at meetings and responded to email queries from all the other 
researchers involved. Dr Mike Jones’ advice in this area was very useful especially with regards 
to keeping the results concise. 
 
Both of the projects involved going beyond the techniques I had learned in the coursework 
component of the Masters course.. The prostate tumour analysis involved investigating how 
interval censored survival data could be analysed and how sample sizes for longitudinal studies 
could be calculated. The kidney project involved learning how complex surveys can be analysed 
using logistic regression while taking into account their sampling design. 
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 Although both projects had relatively clear and simple research questions, how these questions 
were addressed demonstrated to me that statistical analysis is not neatly compartmentalised into 
linear models, survival analysis, longitudinal data etc as in the coursework. The prostate tumour 
analysis involved using methods learned in Survival Analysis and Longitudinal and Correlated 
Data, and the kidney analysis involved material from Clinical Biostatistics, Health Indicators and 
Surveys and Categorical Data Analysis. 
 
Ethical considerations 
The tumour analysis project was carried out on live animals, which ultimately resulted in their 
death. The conduct of this experiment was to be passed by the University of Sydney’s Animal 
Ethics Committee to ensure the mice were cared for appropriately. 
 
The data from the kidney study all came from population surveys that had been carried out by 
other agencies. Each of these studies received ethical approval regarding the conduct of the 
surveys.  
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 Project A 
Project title 
Analysis of tumour growth data using survival curves and mixed models  
 
Location and dates 
School of Public Health, University of Sydney 
August 2005 – November 2006 
 
Context 
Dr Andrew Richards was conducting an experiment to examine the effects of non-steroidal anti-
inflammatories on the growth of advanced prostate tumours amongst laboratory mice. Dr 
Richards sought my advice on how he could analyse the data collected. He had considered using 
survival analysis methods but at the time did not have the skills required to complete this 
analysis. I also advised Dr Richards that as he had collected the size of the tumours at different 
time points, alternative methods to survival analysis could be used. 
 
Student contribution 
I met with Dr Richards on several occasion to discuss the data he had collected, how I thought it 
could be analysed and to provide interpretation of the final results. I carried out all analysis 
myself after extensive consideration of the appropriate methods to use. Dr Timothy Dobbins 
provided assistance in clarifying certain statistical issues. 
 
Statistical issues 
The data collected could be analysed in a number of different ways. The statistical issues 
involved deciding which of the methods would be appropriate. The possible methods included the 
survival analysis of right, as well as interval, censored data, general estimating equation methods 
(GEE) and linear mixed models.  
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 Also, I further extended my knowledge of longitudinal data analysis by investigating how the 
sample size for such studies could be calculated. This had not been covered in the coursework. 
 
Acknowledgements 
I would like to thank Dr Andrew Richards for allowing me to analyse his data, and Dr Timothy 
Dobbins and Dr Judy Simpson for providing advice as the analysis progressed. 
 
Student declaration 
I declare that this project is my own work, with guidance provided by my project 
supervisor, Dr Timothy Dobbins, and that I have not previously submitted it for academic 
credit.   
 
____________________________ 
Kevin McGeechan 
 
____________________________ 
Date 
 
 
Supervisor declaration  
Kevin performed the majority of this project independently. He was instrumental in meeting with 
Dr Richards, proposing and performing the appropriate analyses and communicating the results to 
Dr Richards. I provided minimal supervision in assisting Kevin communicate and interpret the 
models used in the project. 
 
____________________________ 
Dr Timothy Dobbins 
 
____________________________ 
Date 
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 Analysis of tumour growth data using survival curves 
and mixed models
 
Background 
Prostate cancer is one of the most frequently diagnosed cancers amongst men in Australia 
(AIHW, 2006) and the current treatment for men with advanced prostate cancer is androgen 
withdrawal. Androgen withdrawal is carried out by either chemically, or surgically, castrating the 
patient. This delays the growth of the tumour, however after a certain time the tumour inevitably 
begins to grow again. This stage is known as androgen independence. There have been studies 
conducted recently on mice to determine whether different therapeutic strategies could extend this 
time to tumour re-growth (or time to androgen independence) (Eigl, 2005. Nicholson, 2004). One 
such study was carried out by Dr Andrew Richards, a Master of Surgery student at the University 
of Sydney. 
 
The research project’s objective was to investigate whether certain drugs could inhibit the growth 
of advanced prostate cancer tumours which had been grafted onto a group of 73 mice. Dr 
Richards’ description of the project was as follows -  
 
Thymus deficient male nude mice of similar ages were acquired through The University 
of Sydney Laboratory Animal Services (LAS). All 73 mice were xenografted with the 
LNCaP human prostate cancer cell line on roughly the same day (+/-2). Animals were 
marked and randomised to 12 boxes. (There were six mice in 11 boxes, and seven mice in 
one box.) 
 
Ethics approval was obtained from University of Sydney’s Animal Ethics Committee (AEC 
approval no: K26/3-2005/3/4105). 
 
Once tumour reached an index volume (263mm3) as determined by twice weekly calliper 
measurement, animals were castrated to effect androgen withdrawal (the standard treatment for 
advanced prostate cancer) and implanted with a subcutaneous pump delivering 1 month of 
constantly infused vehicle control (Group 1), pure celecoxib (Group 2), celecoxib from tablets 
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 (Group 3), ibuprofen (Group 4) or indomethacin (Group 5).  (All mice within each box were 
assigned to the same group.) 
 
We know that, after initial inhibition or shrinkage of tumours with castration, they will all begin 
to grow again and become androgen independent. Once the tumour grows to greater than 105 
mm3 above its castration size, we call it androgen independent. 
 
Our hypothesis is that these anti-inflammatory drugs will prolong the time to androgen 
independence. 
  
In addition to the above description Dr Richards also stated that for some mice the time to 
androgen independence may not be available as they either did not reach androgen independence 
before the experiment finished or because the mice had to be euthanased for reasons unrelated to 
the treatment before they reached androgen independence. Table 1 provides the number of mice 
in each treatment group and the number who reached the index volume of 263mm3. 
 
Table 1: Number of mice in each treatment group 
Treatment group 
Number of mice xenografted 
with tumour 
Number of mice whose tumour 
reached 263mm3
Control 25 19
Celecoxib 12 9
Celecoxib from 
tablets 12 9
Ibuprofen 12 9
Indomethacin 12 10
Total 73 56
 
Dr Richards intended method of analysing these data was to implement  survival analysis 
techniques using the time to androgen independence as the outcome. He was enrolled in the 
survival analysis course at the School of Public Health due to commence in two months time, 
although he had already begun his experiment and had been monitoring the mice for over a 
month. By the time the course began his experiment would be complete and his data would be 
ready to analyse. 
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Initial advice 
My advice to Dr Richards was that survival analysis would be an appropriate method to analyse 
such data because the outcome he wished to compare between groups was the time until an event 
happened (from implant until androgen independence) and because some of these times may be 
censored (the time till androgen independence was not available due to mice being euthanased or 
not reaching androgen independence before the experiment was complete). However, there were 
a number of issues that he should consider:  
 
1) the total sample size was 73 mice and these were allocated to five different 
treatments (Table 1). Before doing any power calculations I suggested that although 
73 may seem a reasonable sample size when this is split amongst five groups the 
power of a test to detect a difference between the treatments may be low. I asked 
whether there could be a way of grouping the treatments, or was the difference 
between each treatment important? 
 
Dr Richards stated that although four different types of NSAIDs had been given, 
whether an NSAID of any kind would have an effect on tumour growth was also of 
interest. 
 
 
2) The mice were randomly allocated to each of the treatments by the box to which they 
were allocated and each box contained six mice (with the exception of one box which 
contained seven mice). Were the mice in different boxes managed and monitored in 
the same way and were there any other potential factors that he had recorded (or not 
recorded) that may influence the growth of the tumours?  
 
The mice had been bred to be as similar as possible and since birth had received the 
same feeding and care. There were no other factors that Dr Richards could think of 
that would influence the tumour growth. 
 
3) Were there any other ways of defining the outcome of treatment other than time to 
androgen independence that he was aware of and would have some clinical meaning? 
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 For example, had he considered calculating the area under the curve of the tumour 
growth for each mouse, or was the rate of increase in tumour size over time a 
measure that would have some clinical meaning? 
 
The rate of increase in tumour size was a clinically meaningful measure that Dr 
Richards had come across, however he was not aware of the usefulness of the area 
under the curve. 
 
 
Having considered these issues, my advice to Dr Richards was that the data could be analysed 
using survival analysis with time to androgen independence as the outcome. This would involve 
comparing survival curves of mice given the placebo and mice given an NSAID using the log-
rank test. The mice on the different NSAIDs would be grouped together should the power of the 
study to identify a meaningful difference be too low when all five groups were used. I asked Dr 
Richards to provide me with an estimate of the difference in survival rates he would consider to 
be clinically meaningful. The estimate he provided was an increase in time to androgen 
independence of 50% and he estimated that the average time to androgen independence would be 
around 30 to 60 days. 
 
As there were no other potential factors to be accounted for, there was no need to conduct more 
complicated survival analyses using, for example, Cox regression. The analysis to be undertaken 
would be relatively straight forward and Dr Richards would be able to carry this out after his first 
few weeks of his survival analysis course, although if he wished the results sooner then I would 
be available to carry out the work. 
 
In addition to comparing survival analysis I also suggested that other analytical methods could be 
employed that may be more powerful than the log-rank test. These methods rather than using one 
single data point for each mouse – time to androgen independence – would utilise all the tumour 
size measurements to describe the differences in tumour growth between the groups. The methods 
I suggested were: a summary measures approach where a single measure is calculated for each 
mouse (eg area under the curve) and then these measures are  compared between groups using 
simple statistical tests such as the two sample t-test (Matthews, 1990). Other possible analytical 
methods would be the use of Generalised Estimating Equations (GEE) (Diggle, 1994) or mixed 
models which describe each mouse’s tumour growth over time (Verbecke, 2000). 
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Original data 
I received an Excel dataset from Dr Richards which contained for each mouse the tumour size at 
each occasion it was measured. The table below is an example of the data for the first seven 
measurements for mice that were placed in box 2, one of the boxes containing mice that were in 
the control group. Each box contained six mice and mice within each of the boxes had their 
tumour volume measured on average every 3.5 days. A row of observations is the measurements 
made for a single mouse and each mouse within a box was identified by ink marks on their body 
(shown in the first column). 
 
Table 2: Example of Excel data received 
VOLUMES (l^2 *w)        
Day 21 24 27 31 34 38 41
DATE 21.6.05 24.6.05 27.6.05 1.7.05 4.7.05 8.7.05 11.7.05
BOX2 (Control)        
left  119.4 148.1 140.6 174.0 241.3 275.0 260.7
right 103.6 131.4 107.1 125.2 146.8 117.4 153.7
left and right  196.1 199.2 267.8 199.6 208.9 348.2 320.6
left * 2  138.6 183.5 291.8 335.4 301.8 545.7  
right *2   45.9 80.3 75.1 150.1 191.4 169.5
no mark  132.9 289.7 219.7 212.3 343.5 311.6 272.8
 
For each mouse the first number to appear in bold indicates the occasion when the tumour 
reached an index volume of 263mm3 and so when the mouse was surgically castrated and fitted 
with the surgical device that delivered the drug.  
 
Dr Richards also provided an Excel datasheet which would be more amenable to survival analysis 
methods. An example of these data are showing Table 3. This table uses the original coding 
scheme that Dr Richards used when he entered the data. 
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 Table 3: Excel spreadsheet used to derive data for survival analysis 
 uniqueid group tumour formed* event+ Time at event#
BOX2 (Control)     
left 7 1 0 0 17 
right 8 1 0 2 28 
left and right 9 1 0 0 16 
left * 2 10 1 0 0 10 
right *2  11 1 0 0 30 
no mark 12 1 0 0 27 
* 0 = Yes, 1 = No 
+ 0 = Androgen independence, 1 = euthanased at 2 months, 2 = other death 
# Number of days from implanting of drug delivery device until the event 
 
These data gave each mouse a unique identifier and identified to which treatment group they 
belonged. The variable tumour formed indicated whether the tumour reached the index size of 
263mm3 and so whether the mice were implanted with the drug delivery device. The variable 
event recorded whether after implantation the tumour increased in size by 105 mm3 (indicating 
the tumour had reached androgen independence) or whether the mouse had to be euthanased 
before this time. The time at event was the time from the implanting of the drug delivery device 
until the tumour reached androgen independence, or the time of euthanisation. 
 
Evaluation of the appropriate analysis methods to be used 
Right and interval censored data 
One of the simplest ways to compare two survival curves is using the log-rank test. In brief, this 
test compares the observed number of events in each treatment group with the number of events 
that would be expected if the survival curves were the same for each group. This comparison 
takes place at every time when an event occurs and the differences between the observed and 
expected numbers of events are then summed over the total follow up time. Large differences 
between the observed and expected numbers suggest that the survival curves are not the same. 
Whether the differences observed may have occurred by chance can be determined by comparing 
the result of the calculations with a Chi-squared distribution. However, use of the log-rank test 
assumes that the actual event times are known. On seeing the first Excel datasheet I realised that 
this may not be the case with these data. 
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The problem I saw was that although the endpoint was defined as being the time from surgery 
until the tumour grew by 105mm3 it was not possible to exactly determine when this happened as 
the tumour volume was only measured, on average, every three days. These types of data are 
known as interval censored data as the time when the event occurred is known only to have 
occurred within a specific interval (Hosmer, 1999).  
 
The most common type of data encountered in survival analysis is right-censored data and the 
simple survival analysis methods, such as the log-rank test, assume that the data are right-
censored. If data are right censored then we know the time at which the event happened, or the 
last time at which the subject was known not to have experienced the event. Interval censored 
data require different methods of analysis to right-censored data. However, having examined 
recent papers that analysed data from similar trials (Nicoholson, 2004. Eigl, 2005) it seemed that 
researchers ignored the interval censored nature of these data and proceeded as if the data were 
right censored. They provided no justification for this. 
 
I decided to analyse the data ignoring the interval censored nature with the following justification. 
In the worst case scenario we would underestimate the median time until androgen independence 
of one group by the maximum number of days between measurements and overestimate the 
median for the other group by the same number of days. The maximum time between 
measurements was 4 days. This means that there could be a potential bias in the estimate of the 
difference between the median times to androgen independence of 8 days.  
 
Dr Richards indicated that a meaningful difference between treatments would be an increase in 
time to androgen independence of 50% - this would equate to 15 days if the median in the control 
group was 30 days. Therefore when interpreting the final result comparing the median time of the 
two groups it should remembered that the difference between median times may be biased by up 
to 8 days and a difference in median times of between 7 and 15 days may be suggestive of a 
meaningful difference. 
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 Power calculations for five and two group comparisons  
Having advised Dr Richards that he would have a more powerful test if he compared two groups 
rather than five I then carried out power calculations using the power and sample size program PS  
(Dupont, 1997)) for the two group comparison. For the five group comparison the formula (Lee, 
1992)–  
 
( )2log
),,1(2
ke
d a
Kn βατ −=  
 
provides the sample size required in each group where K is the number of groups 
),,1(2 βατ −K  is a non-centrality parameter. The non-centrality parameter depends upon the 
number of groups being compared (K), the power (1-β)  and the required significance level (α). In 
this instance it equals 11.935 where 5 groups are to be compared with a power of 80% and a 
significance level of 0.05. Finally,  is the largest ratio of the mean survival times between 
groups. In this experiment it is 1.5. The required number of mice in each group is calculated to be 
146.  
ka
 
In the experiment there were on average 14.6 mice per group, ten percent of what is required. 
Therefore, the power with 14.6 mice per group (on average) to detect the difference of 50% 
would be approximately 6% (Armitage, 2002). In fact there were 12 mice in the four drug groups 
and 25 in the control group. The unequal numbers in the groups would actually provide less 
power than 6%. 
 
If all the treatment groups are combined then the power can be calculated for a test comparing 
two groups - the treatment group with the control group. Table 4 shows that although comparing 
two groups provides a more powerful test the chance of detecting a difference should it exist is 
still relatively poor. We would detect a difference in median time of 50% in only 38% of 
experiments. Commonly a power of 80% is used when designing experiments. The 38% power is 
still much better than the 6% power of the 5 group comparison. Therefore I decided that the best 
approach would be to combine the four drug groups in one and proceed comparing the mice who 
received an NSAID with those in the control group. 
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 Table 4: Power of the log-rank test to detect a difference in median time till androgen 
independence of 50% 
Median time till androgen 
independence for control group 
Number of groups to 
be compared 
Power to detect a difference 
of 50% in median time 
30 days 2 38%
 5 6%
 
 
Summary measures analysis 
The main outcome of the study is time to androgen independence and this is defined by an 
increase in tumour volume of 105mm3. The tumour volume was measured every 3 days and the 
measurements for an individual mouse can be used to produce a summary measure (eg rate of 
tumour growth) for that mouse. The summary measures are then compared between the groups. 
Two approaches to a summary measures analysis that would be appropriate for this experiment 
would be to use the area under the curve or the rate of increase in tumour volume (Matthews, 
1990).  
 
In the area under the curve approach for each mouse the total area under their growth curve is 
calculated and then the mean areas for the two groups (those on an NSAID and those in the 
control group) is compared using a two sample t-test. For the rate of increase method ordinary 
least squares is used to fit a line to the data for each mouse. The mean regression coefficient for 
the two groups is then again compared using a two sample t-test. It would also be possible to 
extend this method and fit a quadratic curve to the growth curve for each mouse. This would 
allow tumour size to fall before beginning to increase which is biologically plausible given Dr 
Richards’ description of tumour growth – “We know that, after initial inhibition or shrinkage of 
tumours with castration, they will all begin to grow again”. Fitting a quadratic would mean 
having two parameters to compare for each group of mice – the rate of increase at a certain point 
and the curvature of the fitted line. As the rate of change will alter as time increases then the point 
at which the curves are compared is important. Comparing the curves at the time of castration 
may provide a different result to another time, so a clinically meaningful point should be chosen. 
 
These summary measures analyses are problematic in this dataset. Some mice were euthanased 
before the end of the study, either because they had reached androgen independence or for other 
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 medical reasons, and so the number of tumour volume measurements available for each mouse 
was different. This would mean that mice who were not euthanased would have more tumour 
measurements recorded and so their area under the curve may be greater. In addition, the 
regression coefficients estimated for those mice euthanased and those not would have been based 
on different numbers of measurements. Those euthanased would have fewer measurements and 
so the estimated rate of increase would have been less accurate in this group. The summary 
measures approach was decided not to be appropriate for these data for these reasons. 
 
 
GEE or mixed models 
The two other methods of analysing longitudinal data – generalised estimating equations (GEE) 
approach and linear mixed models – could possibly be used to analyse these data. If all of the data 
recorded for each mouse are to be utilised then these methods are necessary as the tumour 
volumes for each mouse are correlated. Simple linear regression assumes that each observation to 
be analysed is independent of the others. The two methods – GEE and mixed models – take into 
account the correlation amongst observations and so provide correct point estimates and standard 
errors for the estimated differences between groups. However, which of the two methods is 
appropriate for these data is dependent upon the model that we fit to the data and the assumptions 
we make about that model. 
 
In the GEE approach a marginal model is specified. This models the expected value of the 
outcome (tumour growth) as a linear function of the covariates (drug group and time since 
surgery) with the correlation between observations specified separately to have a particular form, 
and those observations with the same values of covariates are assumed to have the same 
correlation structure. Generalised estimating equations are then used to provide estimates and 
standard errors of the parameters of interest. The results obtained provide the population average 
effect of the covariates on the outcome. However, if the correlation structure is wrongly specified 
then robust methods will still provide valid estimates of the parameters and standard errors, so 
long as certain conditions regarding missing data hold (see the discussion of missing data below). 
 
The linear mixed model also assumes a linear relationship between the outcome and the 
covariates. However, in this case the parameters of the linear relationship are allowed to vary 
between individuals. These are the random effects of the model. The term mixed comes from the 
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 fact that these random effects are mixed with fixed effects. In the mixed model the fixed effects 
provides an estimate of the effect a covariate would have on an individual’s outcome, and in the 
linear mixed model this also gives the population average effect of the covariates. This is not the 
case in a non-linear mixed model.  
 
In the current analysis, each individual mouse has their own individual parameters that describe 
the growth in tumour size over time (random effects) but there is also a population average 
growth curve (fixed effect of time). The correlation that is observed between observations over 
time for an individual is due to their underlying growth curve which cannot be observed (Liang, 
1993), but rather than specifying a particular form for this correlation structure as in the GEE 
method, the parameters that are included in the model as random effects will determine how this 
observed correlation is estimated. One result of the more detailed specification of the linear 
mixed model is that the effect of the covariates for a particular individual (ie subject specific 
effects) can be estimated rather than simply the population average effect. 
    
Another point of difference between the GEE and mixed models approach is how the two 
methods deal missing data. Missing data can be classified into missing completely at random 
(MCAR), missing at random (MAR) and missing not at random (MNAR). In terms of the two 
approaches the difference lies in whether the data are missing completely at random or missing at 
random.  
 
Missing completely at random means that the probability of a particular observation being 
missing (such as the tumour volume measured on a particular day for an individual mouse) does 
not depend upon any other observation. Missing at random means that the probability of and 
observation being missing may depend on other observed values, but the fact that it is missing 
does not depend on its own value. 
 
The data from the mice experiment are missing at random, not missing completely at random. A 
mouse that has been euthanased cannot have a tumour volume measured, the measurement is 
missing. The reason the measurement is missing is because of the previous values of the tumour 
volume, however it does not depend upon the current tumour volume (if it could have been 
measured). 
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 In order to use the GEE method we must assume that any missing data are missing completely at 
random. It is possible to relax this assumption so that the data are only assumed to be missing at 
random. However, using a GEE method in this case we would have to correctly specify the 
correlation structure. An incorrectly specified model fitted using GEE where the data are missing 
at random produces biased results (Cnaan, 1997). The mixed model approach, in contrast to the 
GEE approach, provides unbiased estimates in situations where the data are missing at random. 
 
The mixed models approach has a further advantage over the GEE approach. In the current 
experiment mice were kept in boxes with six mice in each box. It could be possible that mice in 
different boxes received slightly different treatment and so mice from the same box would be 
more likely to have similar experiences than mice in different boxes. There is therefore the 
potential for some for of clustering of data within boxes. The data are already clustered over time 
as repeated measures have been made for each mouse. The added clustering level of box results 
in two different levels of clustering. The mixed models approach can incorporate many levels of 
clustering, whereas in the simple GEE method we are restricted to one – either over time, or 
within box. Although this question will not be addressed in the current project it would be another 
reason for choosing the mixed models approach over the GEE method. 
 
The mixed models approach was therefore chosen to analyse these data as the tumour volumes in 
the study were missing at random, rather than missing completely at random, and also because it 
would be of interest to develop a model that could estimate the tumour growth for an individual. 
Although less important in this animal experiment, it would become more important if the study 
was extended to human participants. 
 
Within this mixed models approach choices have also to be made regarding the form of the 
model. One of the choices is how to model the variance in the outcome. The variance in the 
outcome is determined by how we model the random effects and what correlation we assume 
there is between observations for an individual. When the data are highly unbalanced, such as in 
this study where at later observation times there were relatively few mice still alive, the 
recommended approach is to assume that observations are independent within an individual. The 
structure of the variance in the outcome is then determined wholly by how the random effects are 
specified (Cnaan, 1997).  
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Analysis proposed 
Compare the mice in the control group with those who were in the drug group using 
• Kaplan Meier curves and descriptive statistics of time from implantation with drug 
delivery device until androgen independence 
• Log-rank test to determine whether the survival curves are different 
• Mixed model analysis of time from implantation with drug delivery device until 
androgen independence 
 
 
Results 
 
Mice who reached initial tumour volume 
Only 56 of the mice implanted with the tumour reached the initial tumour size of 263mm3. This 
reduced the power of being able to detect the proposed difference to 30%. However, one positive 
observation was that the median tumour volume was identical for the mice in the two groups 
which reached the initial tumour size (table 5). As the mice up until this point were virtually 
identical any difference would have been due to chance variation, or a bias in the measurement of 
tumour volume as described earlier. This provides some evidence that such a bias has not 
occurred. 
 
Table 5: Description of mice whose tumours reached index volume (> 263mm3) 
 
Number of 
mice 
Mean tumour volume (mm3) at 
time of surgical implant 
Median tumour volume (mm3) 
at time of surgical implant 
Control 19 303 291
Drug 37 297 291
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Log rank test 
Table 6 provides the median time to AIC for both the drug and the control groups and the results 
of the log-rank test comparing the survival curve between groups. The drug group had a higher 
median time too androgen independence (35 days) compared to the control group (30 days) 
although this difference was not significant (χ2 = 0.39, df = 1, p = 0.53). For the great majority of 
the follow-up period the survival curve for the drug group remains above that of the control group 
(figure 1).  
Figure 1 
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Table 6: Log rank test comparing time until androgen independence 
 
Number 
of mice 
Number 
who 
reached 
AIC 
Number 
censored 
Median 
time till 
AIC 
(days) 
95% 
Confidence 
Interval 
Log-
Rank 
test Df 
p-
value 
Control 19 14 5 30 (17, 46) 0.39 1 0.53
Drug 37 21 16 35 (24, 48)   
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 Mixed models 
The mice were examined on average every 3.5 days and post-surgery the median number of 
tumour volumes recorded for the mice was 9. Figure 2 shows the tumour volume trajectories for 
each mouse in the drug and control groups. Individual trajectory plots were also examined for 
each mouse in order to determine whether a transformation of the data would be appropriate. This 
was not felt to be necessary. 
 
 
Figure 2: Trajectory plots for tumour growth with mean at each time point overlaid 
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 Figure 3: Mean tumour volume by drug group 
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The trajectory plots show little indication that the drug groups tumours are growing at a slower 
rate. Figure 3 plots on the same graph these mean tumour volumes. This plot again provides little 
evidence of any difference between the two groups in tumour volume. 
 
Two different random effects models were fitted to the data. One assumed that the growth in 
tumour volume was linear, ie tumour volumes changed at a constant rate. The second assumed 
that growth was quadratic, ie the rate of change in tumour volumes changed over time. The 
quadratic model would thus be able to capture the change in tumour volumes that Dr Richards 
had described in his original description of the study -  “after initial inhibition or shrinkage of 
tumours with castration, they will all begin to grow again. 
 
The models were constructed as two-level models. The level 1 model describes how each 
mouse’s tumour volume changes with time, and the level 2 model describes how these changes 
differ between mice. So for the linear model, level 1 states that an individual mouse’s tumour 
grows in a linear fashion and level 2 states that the starting volume (intercept) and the rate of 
change of tumour volume (slope) for each mouse may be different. One advantage of specifying 
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 the model in two levels rather than directly specifying the mixed model is that it ensures that in 
the final mixed model each random effect had a corresponding fixed effect. 
 
Model assuming linear change 
Level one model 
ijijiiij surgpostY εππ ++= _21  
 
Yij = volume of tumour for mouse i at time j 
=i1π intercept for mouse i (ie tumour volume at time 0) 
=i2π slope for mouse i (ie rate of change in tumour growth per day) 
),0(~ 2σε Nij  residuals around the fitted line for mouse i 
 
Level two model 
iii drug 111101 λββπ ++=  
10β = average population intercept for mice in drug group 0 (control mice) 
11β = change in the average population intercept associated with being in drug group 1 (drug 
mice) 
idrug  = drug group for mouse i. 0 if control mouse, 1 if drug mouse. 
 
iii drug 221202 λββπ ++=  
20β = average population slope for mice in drug group 0 (control mice) 
21β = difference in the average population slope associated with being in drug group 1 (drug 
mice) 
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N
i
i  variation between mice in intercepts (τ11) and slopes (τ22) and 
covariance between the two (τ21). 
 
Combined model 
( ) ( ) ijijiiiiij surgpostdrugdrugY ελββλββ ++++++= _2212011110  
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 ( ) ( ) ijijiiijiijiij surgpostsurgpostdrugsurgpostdrugY ελλββββ +++∗+++= ___ 2121201110
 
 
Volume since surgery - quadratic 
Level one model 
( ) ijijiijiiij surgpostsurgpostY επππ +++= 2321 __  
 
Yij = volume of tumour for mouse i at time j 
=i1π intercept for mouse i (ie tumour volume at time 0) 
=i2π rate of change in tumour growth at time 0 for mouse i  
=i3π curvature of the quadratic for mouse i 
),0(~ 2σε Nij  residuals around the fitted line for mouse i 
 
Level two model 
iii drug 111101 λββπ ++=  
10β = average population intercept for mice in drug group 0 (control mice) 
11β = change in the average population intercept associated with being in drug group 1 (drug 
mice) 
idrug  = drug group for mouse i. 0 of control mouse, 1 if drug mouse. 
 
iii drug 221202 λββπ ++=  
20β = average population rate of change in tumour growth at time 0 for mice in drug group 0 
(control mice) 
21β = difference in the average population rate of change in tumour growth at time 0 associated 
with being in drug group 1 (drug mice) 
 
iii drug 331303 λββπ ++=  
30β = average population curvature of the quadratic for mice in drug group 0 (control mice) 
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 31β = difference in the average population curvature of the quadratic for associated with being in 
drug group 1 (drug mice) 
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 variation between mice in intercepts (τ11), slopes (τ22) and 
curvature  (τ33) and covariance between the three parameters. 
 
 
Combined model 
( ) ( ) ( )( ) ijijiiijiiiiij surgpostdrugsurgpostdrugdrugY ελββλββλββ +++++++++= 2331302212011110 __
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The data were also centred at 14 days post surgery. The reason for this was that in the models 
specified the parameter estimates provide the differences between the two groups at time zero. If 
time zero was taken to be the day of surgery then we would expect there to be no difference 
between the groups in their rate of change in tumour volume as they had not begun their different 
treatments. Fourteen days post treatment was decided as a reasonable time for treatment 
difference in rate of change to become apparent.  
 
These two models were fitted using PROC MIXED (see appendix for program). Goodness of fit 
was assessed using AIC and BIC (Table 7), where lower values imply a better fit. The REML 
criteria were not used to judge goodness of fit as the two models that have been fitted have 
different mean models specified. This means that the REML functions are based upon different 
observations and so can no longer be directly compared (Verbecke, 2000). The model that 
assumed quadratic change in tumour volume fitted the data better using the AIC and BIC 
measures as they were both lower for the quadratic model.  
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 Table 7: Model fit statistics 
 AIC BIC 
Quadratic increase in volume 5564 5578 
Linear increase in volume 5634 5642 
 
The fitted population average curve for the control mice is 
( )2_*183.0_3.41.319 surgpostsurgpostY ++=  
 
and for the mice in the drug group is  
 ( )2_*145.0_6.21.302 surgpostsurgpostY ++=
 
Figure 4 shows the fitted population average growth curve using the quadratic model for drug and 
control groups. There was no evidence of any difference between these curves (F2,19.1 = 0.54, p = 
0.59). There was no evidence of a difference in rate of growth at day 14 (t = -0.94, df = 18.5, p = 
0.37) or in the curvature of the lines (t = -0.73, df = 20.7, p = 0.47). Centring the data at 28 days 
rather than 14 days had no effect on results. Centring beyond 28 days resulted in the model failing 
to converge. 
 
Note that as multiple random effects have been modelled and the data are unbalanced the t and F 
tests are only approximate, with the degrees of freedom estimated by  the Satterthwaite approach. 
This method often produces non-integer values for the degrees of freedom as seen here. 
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 Figure 4: Fitted population average growth curves 
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These curves look quite different to the observed values. The reason for this is that there are very 
few mice with observations at the end. Fitting the individual predicted curves we see that the 
model fits the data quite well (figure 5). This is also demonstrated by plotting the average of the 
observed and predicted volumes of these mice still alive (figure 6). 
Figure 5: Trajectory plot showing observed tumour growth and subject specific predicted 
growth curves 
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Figure 6: Mean of observed and predicted tumour volumes 
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Discussion 
The analysis has provided little evidence that the use of NSAIDs delays the growth in prostate 
tumours and hence prolongs the time until androgen independence. Two methods of comparing 
the change in tumour volume have been used. The log-rank test compared the time until androgen 
independence for the two groups and the linear mixed models approach compared the rate of 
change in tumour volume. One of the reasons for a failure to detect any difference may have been 
the low power of the experiment. 
 
The log-rank test had very low power (30%) to detect the stated difference of an increase in time 
to androgen independence of 50%. An increase of 50% is a rather large increase to detect. A 
smaller intended detectable difference would have resulted in an even lower power. Therefore the 
problem of low power in this experiment is the sample size used, and perhaps the unequal 
allocation between groups.  
 
There were only 56 mice that were included in the final analysis. These are the mice whose 
tumours reached the required initial volume. Thirty-seven of these mice were in the drug group 
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 and 19 in the placebo: ratio of roughly 2:1. In experiments with a given sample size a more 
powerful study usually results when equal numbers of subjects are in the comparison groups. In 
some studies this is not possible, for example case-control studies of rare diseases and hence 
multiple control subjects may be chosen for each case. However, the total number of subjects is 
less for an equivalently powered study where there are equal numbers. In this experiment if there 
had been equal numbers in the drug and control group (28 in each group for a total of 56) the 
power would have increased to 33% from 30% with the unequal groups used - a very small gain 
in power. 
 
This means that the only way that this study could be repeated and have any chance of identifying 
a meaningful difference of 50% would be to increase the sample size. In order to achieve the 
standard 80% power, with a significance level of 0.05 and a difference to be detected of 50% 
there would have to be 192 mice in total, assuming equal allocation, and 214 mice, assuming the 
ratio of drug to placebo mice was 2:1. 
 
In my advice to Dr Richards I had stated that the advantage of using the mixed models approach 
rather than the log-rank test would be that it would provide a more powerful test. The only 
justification I gave for this statement was that the mixed models approach uses more data than the 
log-rank test. The mixed models approach used all of the weights recorded and the times that they 
were recorded, whereas the log-rank test only uses the time that the tumour volume takes to 
increase by a certain size. Matthews in his description of the summary measures approach 
cautions against being seduced by the vast amounts of data that are available in longitudinal 
studies. However, it is true that the mixed models approach will provide a more powerful test as 
the outcome is continuous. 
 
The book Analysis of Longitudinal (Diggle, 1994) data provides a formula for the sample size 
required in longitudinal studies where the measure of interest to compare between two groups is 
the rate of change. The formula for the sample size is 
 
( ) ( )
22
22 12
dns
zz
m
x
ρσβα −+=  
zα and zβ are the usual points on the standard Normal distribution based on the 2-sided 
significance level (α) and the power (1-β). The value σ2 and ρ are the variance of the variable 
under study (eg tumour volume) and the correlation of these repeated measurements within 
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 subjects – the formula assumes a constant variance and correlation over time. The number of 
measurements per subject is n and s2x gives the variance of the measurement times. The smallest 
detectable difference in the rate of growth is given by d. 
 
We can apply this formula to the mice experiment in the following way. On average there were 
3.5 days between measurements, allowing for 9 measurements per mouse total follow-up would 
have been 31.5 days (the maximum a mouse was followed for was actually 56 days). 
 
The median time to reach androgen independence for the control group was 30 days, and 
androgen independence was defined as an increase in tumour volume of 105 mm3. This equates to 
a rate of growth of 3.5mm3 per day. An increase in the median time to androgen independence of 
50%, to 45 days, would equate to a rate of growth of  2.3mm3 per day. So the difference in rate of 
growth we wish to detect is 1.2mm3 per day. 
 
From the data the estimate of σ  (=71.2) was obtained by taking the average of the standard 
deviations of the volumes measured between the time of surgery and 30 days following it. 
Strictly, σ2 is the variation in tumour volumes not explained by the model. The estimate obtained 
from the data would be an overestimate of this because, although the variation due to time has 
been accounted for by taking the average variation at different time points, the variation due to 
the random the random intercepts and slopes of the mice has not. The overestimation of σ will 
result in an overestimation of the sample size. The correlation (ρ) between measurements at 
surgery and 3 days post surgery was 0.28. The table below displays the sample size required in 
each group for various σ and ρ. 
 
Table 8: Sample size required in each group to detect a 50% change in median time until 
androgen independence with 80% power and significance of 0.05 
  ρ 
  0.1 0.3 0.5 0.8 
σ 50 27 21 15 6 
 70 52 41 29 12 
 90 86 67 48 19 
 
The number required when at the higher variance and when the correlation between repeated 
measures is lowest (m = 86) gives a total sample size required of 172 compared to 192 when a 
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 log-rank test comparing the survival curves is used. In the current data the correlation was close 
to 0.3 and the standard deviation closer to 70 which would suggest the total sample size required 
would be 82 (41 in each group). This is larger than the sample size that the experiment was begin 
with (73) and the number that were finally available to be analysed (56).  
 
There are, of course, a few caveats that much be attached to the above sample size calculations. 
The formula assumes that the variance is constant over time and that there are equal numbers of 
subjects in each group. This has partly been addresses by taking the average of the variances over 
a period of 30 days and the sample size can be adjusted for unequal numbers by using the formula 
–  
 
r
nrm
2
)1( +=  
 
m is the number of subjects in one group, rm is the number in the other group and n is the sample 
size required if the two groups have equal numbers of subjects (SMMR). Using this formula, a 
study with 41 in each group would be equivalent to having 31 in one group and 62 in the other – a 
total sample size of 93. This is still less than the 192 required for the survival analysis. 
 
There are two issues that remain to be resolved with the use of the above sample size formula. 
The formula here assumes a linear increase in tumour volume. The data actually show a quadratic 
increase which means more parameters have to be estimated. Hence, a greater sample size would 
need to be used to provide a similar power. 
 
A final issue is that the calculations assume that each mouse has a measurement at each of the 
time points and every mouse has the same number of measurements. This is not the case in this 
experiment due to the censoring of the data. Again this is likely to inflate the sample size required 
for a given power. The power of the test, and hence sample size required, in repeated measures 
depends not only the number of measurements per individual but also the pattern of missing 
observations (Tu, 2004). 
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 Appendix 1
 
* sort out data for proc mixed; 
data wpp.mice_post_mixed; 
set wpp.mice_post; 
 
* centre post_surg at 14 days; 
post_surg_cen = post_surg -14; 
 
* squared term; 
post_sq = post_surg_cen*post_surg_cen; 
 
*class variable; 
cpost = post_surg_cen; 
 
run; 
 
 
* post surgery; 
*linear; 
title "Linear"; 
proc mixed data=wpp.mice_post_mixed covtest; 
where volume ne .; 
  class id cpost; 
  model volume= drug post_surg_cen drug*post_surg_cen / solution ddfm = 
satterth; 
  random intercept post_surg_cen / subject=id type=un; 
  run;  
 
 
* quadratic; 
  title "Quadratic"; 
proc mixed data=wpp.mice_post_mixed covtest; 
where volume ne .; 
  class id cpost; 
  model volume= drug post_surg_cen post_sq drug*post_surg_cen 
drug*post_sq/  
  solution ddfm = satterth  outp = test outpm = test2; 
  random intercept post_surg_cen post_sq/ subject=id type=un; 
  repeated cpost; 
    contrast "Contrast" drug*post_surg_cen 1, 
     drug*post_sq 1 ; 
  run;  
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 Project B 
Project title 
The Relationship Between Chronic Kidney Disease and Individual-Level Socio-Economic Status: The 
Three Continent Kidney Disease (3CKD) Study 
Location and dates 
March – June 2006, School of Public Health, University of Sydney 
Context 
Researchers from the School of Public Health and the George Institute at the University of Sydney 
collaborated on a project to investigate the association between socio-economic status (SES) and 
chronic kidney disease (CKD). The researchers had access to three different population surveys from 
the USA, Thailand and Australia. Each of the surveys recorded measures of kidney function and also 
information that could be used as measurements of socio-economic status. The measurements chosen 
to use as measures of SES were educational status, total household income and employment status. 
Ethnicity was also recorded in one of the surveys and a secondary aim of the study was to investigate 
whether the association between SES and CKD was similar across different ethnic groups. 
Student contribution 
Several meetings were held with all the researchers to plan the analysis and discuss the results. I also 
met with Dr Mike Jones on many occasions to discuss the ongoing analysis and the responses to 
questions from the other researchers.  
 
I carried out all data management tasks, investigated appropriate ways to code the selected variables, 
performed the agreed statistical analysis and provided interpretation of the results. I also carried out 
additional analyses to provide supporting evidence for the choices made regarding the coding of 
variables. 
 
Statistical issues 
The primary research question was addressed using the relatively simple method of logistic regression. 
However, as each of the surveys had complex sampling designs this had to be taken into account in 
order to obtain correct parameter estimates and standard errors. 
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Other statistical issues encountered were how to assess the agreement between two measurements and 
which type of model is most appropriate in combining results from studies. 
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 Introduction 
Researchers from the School of Public Health and the George Institute at the University of Sydney 
collaborated on a project to investigate the association between socio-economic status (SES) and 
chronic kidney disease (CKD). The researchers had access to three different population surveys from 
the USA, Thailand and Australia. Each of the surveys recorded measures of kidney function and also 
information that could be used as measurements of socio-economic status. The measurements chosen 
to use as measures of SES were educational status, total household income and employment status. 
Ethnicity was also recorded in one of the surveys and a secondary aim of the study was to investigate 
whether the association between SES and CKD was similar across different ethnic groups. 
 
The three surveys used in this analysis were each national representative surveys, however none were 
designed with the specific aim of investigating the association between chronic kidney disease (CKD) 
and socioeconomic status (SES). The National Health and Nutrition Survey (NHANES III) which was 
carried out between 1988 and 1994 is one of a series of surveys undertaken in the USA to provide 
national estimates of the health and nutritional status of the US population (National Center for Health 
Statistics Centers for Disease Control and Prevention, 1996). The InterAsia Collaborative Study of 
Cardiovascular Disease in Asia (InterAsia), carried out between July 2000 and March 2001, was 
designed to provide estimates of cardiovascular risk factors in Thailand and China (He, 2004). The 
Australian Diabetes, Obesity and Lifestyle Study (AusDiab), carried out between May 1999 and 
December 2000, was designed with the primary aim of providing national and state estimates of the 
prevalence of diabetes (Dunstan, 2002). However, each of the studies recorded information on 
creatinine levels, which were used to provide an indicator for the presence of CKD, socioeconomic 
status and other factors that should be taken into account when assessing the relationship between 
CKD and SES. 
 
Data management 
The first task was to combine the data from the three surveys into a common dataset to be analysed. 
This involved translating the datasets into a common format, identifying the SES constructs measured 
in common across the surveys and the data items by which they were represented and coding these to a 
common system. The datasets from each of the surveys were stored in three different formats. The 
NHANES data was stored as SAS transport files, the InterAsia data was stored as a Stata file and the 
AusDiab data was stored as SPSS datasets with its own specially designed interface where specific 
SPSS datasets could be created. Each of the datasets was translated into SAS datasets for analysis. 
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The variables to be used in the analysis then had to be created from the data recorded in each of the 
surveys. Each survey asked questions slightly differently and recorded information in different coding 
schemes. Questions that could be used or combined to provide a common variable had to be found and 
the coding scheme standardised. There was extensive documentation available for the NHANES study 
which made examining the 3,668 variables recorded for NHANES relatively easy. There was also 
good documentation for AusDiab and the subset of data that we requested for this analysis had only 
174 variables. There was minimal documentation for the InterAsia data which made the examination 
of its 412 variables more difficult. 
 
 
Survey design 
While the data management tasks were undertaken several meetings took place with the co-
investigators to clarify the research questions and to agree on an analysis plan. After having identified 
the variables required for the analysis, standardised the coding for each survey and agreed on the 
analysis plan, the next step was to analyse the data. All of the studies used complex sampling designs 
which involved stratified sampling with unequal sampling fractions and clustering. This means that 
simple methods of analysis are no longer appropriate as these methods are based on the assumption 
that individuals within the dataset are independent of each other. The sampling sheme for each of the 
surveys means that this assumption no longer holds. 
 
AusDiab was the simplest design in that it stratified the Australian population by state then within 
each state six census districts were randomly selected (a census district is the smallest geographical 
unit defined by the Australian Bureau of Statistics and on average consists of 225 dwellings). These 
census districts formed the clusters and within the cluster all residents were invited to take part in the 
survey. The InterAsia used four levels of stratification – 1. provinces, 2. political districts, 3. slum or 
non-slum enumeration district and 4. age group by gender. As individuals come from the same area 
the data are also clustered so this also has to be taken into account. NHANES had four levels of 
clustering. The first level was the county level and 81 counties were randomly selected. These were 
then randomly split between the two time periods over which the survey was carried out (phase 1 was 
carried out over the period 1988-1991 and phase 2 was carried out from 1991 to 1994). Within each 
county, city or suburban blocks were then randomly selected and within a block households of 
individuals were selected. 
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Each of the datasets also contained sampling weights to be used in any analysis. The sampling weights 
are the inverse of the probability of being sampled (in NHANES African-Americans and Mexican- 
Americans were over sampled and so had a higher probability of being sampled). These weights also 
provided adjustments for non-respondents. 
 
The choice of sampling design was based on practical as well as statistical considerations. For 
example, the AusDiab study sampled equal numbers from each state. A more precise estimate of the 
national prevalence of diabetes would have been obtained if numbers were sampled proportional to the 
population of each state. However, a secondary aim of AusDiab was to provide estimates at the level 
of each state therefore precision at the national level was sacrificed in order to obtain this. Another 
example is the over sampling in NHANES of African-Americans and Mexican-Americans. 
 
The sampling design needs to be taken into account when estimates are calculated. Estimates derived 
from these studies need to take into account the sampling weights to provide accurate estimates of 
prevalence. The analysis also needs to take into account the stratification and clustering within the 
design. These elements of the sampling design will affect the estimates of the variance of parameters. 
For example, ignoring the clustering within a dataset would generally provide lower estimates of the 
variance, and hence standard errors, as the individuals would be more alike than if the sample had 
been obtained from a simple random sample. Lower standard errors will result in lower p-values 
thereby increasing the type I error rate and hence the chance of declaring an association between SES 
and CKD as significant when in fact no relationship exists. 
 
Methods of analysis 
The association between SES and CKD was estimated using logistic regression. This method was 
chosen because the definition of CKD used in this study was the dichotomous outcome of whether the 
person had a glomerular filtration rate (GFR) below 60ml/min/1.73m2  or not. The design of each of 
the surveys was taken into account when analysing the data by using the SAS procedure PROC 
SURVEYLOGISTIC. This procedure carries out logistic regression where the data have been 
collected from complex surveys and it requires that the variables that identify the strata, primary 
sampling units and sampling weights be specified. Each survey dataset provided fields for primary 
sampling units and stratification variables. 
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 A random effects model was also used to combine the estimates across the three surveys using 
techniques from meta-analysis. The random effects model was chosen as it was assumed that the effect 
of SES varied between the countries, and that this variation was not simply due to sampling 
variability. The fixed effects model would assume that there is one true measure of the effect of SES 
on CKD and that the measures between surveys only differ because of sampling variability. In the 
random effects model it is assumed that the effect of SES on CKD is itself a random variable.  
 
The assumptions for the random effects model appear to be more plausible for these data. It is unlikely 
that the effect of SES on CKD would be the same in each population given the wide cultural and also 
health access differences between the countries. Also, for some measures of SES a relative 
measurement was used (eg below versus above median income). For such variables, how big the effect 
of SES on CKD is will depend upon how much variation there is in the SES measure. 
 
Comparison of two formulae to estimate GFR 
 
Measuring agreement using the Bland-Altman plot 
The outcome investigated in this study was a glomerular filtration rate (GFR) below 60ml/min/1.73m2. 
GFR is a measure of kidney function and a GFR below 60ml/min/1.73m2 is one commonly used 
indication of chronic kidney disease. The GFR is calculated using the serum creatinine and other 
factors such as age, race or body surface area depending on which formula is used. Two of the most 
common formulae used to calculate GFR are the MDRD formula (named after the US Modification of 
Diet in Renal Disease Study) and the Cockcroft-Gault formula. (The Australasian Creatinine 
Consensus Working Group, 2005). 
 
The GFR calculated using the MDRD equation was the method employed in this study as it is 
considered to be the more widely validated and is currently recommended by The Australasian 
Creatinine Consensus Working Group (2005). However, as a previous publication investigating the 
prevalence of kidney disease amongst the Australian population (Chadban, 2003) used the Cockcroft 
Gault formula as at the time it was the more commonly used formula in Australia, it was of interest to 
compare whether using either equation influenced the estimated association between SES and CKD. If 
the two equations provide similar estimates of GFR (ie agree with each other) then it would not matter 
which equation was used as to estimate GFR as the effect on the association between SES and CKD 
would be small.  
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One way to investigate the agreement between the two measurements would be to plot each variable 
against the other. The resulting plot should be on the diagonal line of equivalence if the measures 
agreed. The data from each of the three surveys is shown in Figures 1, 2 and 3. Also included on the 
plots are reference lines at GFR equal to 60ml/min/1.73m2. Simply calculating the correlation between 
the two measures does not give an indication on whether the measures agree. For instance, their may 
be perfect correlation but one measurement is consistently half of the other measurement. 
 
It is difficult to determine whether the data lie on the diagonal due to the number of observations 
although it is clear that the variation increases as the estimated GFR increases. Bland and Altman have 
suggested a more appropriate graph to compare two measurements which plots the difference between 
the two values against their average (these are shown in figure 4, 5 and 6) (Bland, 1986). If the 
measures agreed then the data points should be a straight band centred around the horizontal zero line, 
with no fanning out or tendency to increase or decrease. (The SAS program for the Bland-Altman 
plots was based on the program presented by Schneider at the SAS Users Group International 
conference (2001).  
Figure 1: Comparison of GFR estimated by the MDRD and Cockcroft Gault methods using 
NHANES data 
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 Figure 2: Comparison of GFR estimated by the MDRD and Cockcroft Gault methods using 
InterAsia data 
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Figure 3: Comparison of GFR estimated by the MDRD and Cockcroft Gault methods using 
AusDiab data 
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 Figure 4: Bland-Altman plot for GFR using NHANES data    
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Figure 5: Bland-Altman plot for GFR using InterAsia data    
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 Figure 6: Bland-Altman plot for GFR using AusDiab data 
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In all three studies there is a clear increase in variation between measurements as the GFR increases. 
This indicates increasing disagreement between the estimates as the true value of GFR increases. Also, 
in all three studies there appears to be a trend to an increasing difference between estimates as the 
GFR increases. This is particularly evident for the AusDiab study. This suggests that the Cockcroft 
Gault equation estimates a higher GFR value than the MDRD equations at higher values of GFR, and 
lower GFR values at lower values. 
Measuring agreement using the Kappa coefficient 
The above analysis has investigated whether the estimated GFR values agree when computed using 
the two equations. In this study however the GFR estimate was not used directly but rather the GFR 
values were categorized into low (<60ml/min/1.73m2), which would indicate the presence of CKD,  or 
not (≥60ml/min/1.73m2). It would be appropriate then to also determine whether the classification of 
people as having low GFR was the same when the two equations are used. The Kappa coefficient 
(Armitage, 2002) was used to determine this. 
 
The Kappa coefficient measures the agreement between categorical variables over and above that 
which may have arisen by chance. The formula for Kappa is 
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where Io is the observed agreement and Ie is the expected agreement. The Kappa coefficient can be 
supplemented by two measurements which provide information on whether the two classifications 
agree when the condition is present and when the condition is absent. The formulae for the two 
measurements are 
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where ppos is the number of agreed positives divided by the average of those classed as positives by the 
two classifications. pneg is similarly defined for the negatives, and a, b, c and d are the usual four cells 
from the 2x2 table of agreement. 
 
Table 1: Comparison of people classified as low GFR using two methods 
  NHANES  InterAsia  AusDiab 
  GFR estimated by Cockcroft Gault 
  <60 ≥60  <60 ≥60  <60 ≥60 
GFR estimated by MDRD <60 858 76 741 120 710 267 
 ≥60 891 8770 565 3672 622 8134 
          
 Kappa 0.59   0.60   0.57  
 ppos 0.64   0.68   0.62  
 pneg 0.94   0.91   0.95  
 
The agreement in each of the studies is reasonable (but also far from perfect) between the two 
classifications, and for each study there is more agreement in classifying subjects who have a GFR≥60 
ml/min/1.73m2, than below 60ml/min/1.73m2, as indicated by the high values of  pneg and the lower 
values of ppos (Table 1) . Although the Bland-Altman plot indicates that the Cockcroft Gault and the 
MDRD equations are not producing equivalent estimates of GFR, the Kappa coefficients suggest that 
once people are classified as having low GFR then the difference between the two equations matters 
less. However, the Cockcroft Gault formula does classify a higher proportion of people as having low 
GFR. 
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In this study a low GFR (below 60ml/min/1.73m2) is regarded as indicating chronic kidney disease 
and the purpose of the study was to examine whether various SES factors were associated with CKD. 
Table 2 below presents the odds ratios calculated for the three different SES factors under study 
(education, income and employment) when CKD is determined using the MDRD formula or the 
Cockcroft-Gault formula.  These odds ratios are presented separately for the three surveys – 
NHANES, InterAsia and AusDiab. Using either method to define CKD there appears to be an increase 
in risk of CKD with lower SES across all three surveys, however many of the confidence intervals for 
the odds ratios contain one. There are no dramatic differences between the results when CKD is 
defined by the MDRD or Cockcroft-Gault formula. 
 
Table 2: Effect on odds ratios when GFR is estimated using MDRD or Cockcroft-Gault 
  
MDRD Cockcroft Gault 
Survey Effect 
Odds 
Ratio
95% Lower
Confidence 
Limit
95% Upper 
Confidence 
Limit
Odds 
 Ratio 
95% Lower
Confidence 
Limit
95% Upper 
Confidence 
Limit
NHANES Education: Average 
vs Greater than 
average 
1.01 0.79 1.30 1.01 0.77 1.31
 Education: less than 
average vs Greater 
than average 
1.31 1.00 1.71 1.37 1.06 1.77
 Income: Below 
median income vs 
Above median 
income 
1.31 0.97 1.76 1.12 0.88 1.42
 Employment status: 
Not employed vs 
Employed 
1.12 0.86 1.45 0.99 0.73 1.34
 Employment status: 
Retired      vs 
Employed 
1.52 1.13 2.03 1.27 0.97 1.66
   
InterASIA Education: Average 
vs Greater than 
average 
1.35 0.96 1.90 1.38 0.99 1.92
 Education: less than 
average vs Greater 
than average 
1.17 0.73 1.88 1.58 1.07 2.31
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MDRD Cockcroft Gault 
 
Survey Effect 
Odds 
Ratio
95% Lower
Confidence 
Limit
95% Upper 
Confidence 
Limit
Odds 
 Ratio 
95% Lower
Confidence 
95% Upper 
Confidence 
Limit Limit
 Income: Below 
median income vs 
Above median 
income 
1.07 0.80 1.42 1.72 1.27 2.32
 Employment status: 
Not employed vs 
Employed 
1.25 0.92 1.70 1.24 0.80 1.92
 Employment status: 
Retired      vs 
Employed 
1.11 0.80 1.53 1.00 0.68 1.49
   
AusDiab Education: Average 
vs Greater than 
average 
0.70 0.52 0.95 0.88 0.68 1.13
 Education: less than 
average vs Greater 
than average 
1.07 0.88 1.30 1.07 0.73 1.58
 Income: Below 
median income vs 
Above median 
income 
1.29 0.91 1.83 1.79 1.18 2.71
 Employment status: 
Not employed vs 
Employed 
1.40 0.96 2.05 1.32 0.80 2.16
 Employment status: 
Retired      vs 
Employed 
2.01 1.28 3.17 2.03 1.31 3.14
 
Neither of the two methods for estimating GFR provides the true value of GFR therefore when these 
methods are then used to classify someone as below or above a certain GFR some people will be 
misclassified. Unfortunately, within the surveys there is no gold standard of GFR to determine which 
of the two estimates has less misclassification and would thereby provide a more accurate result. In 
logistic regression where there is misclassification in the outcome, the resulting estimate of the 
association between the outcome and risk factor will be biased (Luan 2005). The direction of this bias 
will depend on whether there is differential or non-differential misclassification in the outcome. If 
there is non-differential misclassification the bias would be towards the null value, but for non-
differential misclassification the bias could be away from the null rather than towards. In the present 
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 study if SES status is associated with GFR level then there may be non-differential misclassification 
with lower SES more likely to be misclassified. However, in this instance the estimated association 
would still be biased towards the null value. Although the estimates of the association between SES 
and CKD displayed in table 2 may be biased when either equation is used, the associations described 
appear to be broadly consistent no matter which equation is used. 
 
 
Residual confounding 
Residual confounding occurs when a confounder is not completely controlled for in an analysis. This 
could happen if the variable that measures the confounder is categorised into broad groups (Webb, 
2005). Within each broad group the association between the outcome and the covariate may then still 
be affected by the true value of the confounder. In our analysis the outcome is CKD, the covariate is 
SES and the confounder is age which can be categorised into age groups. 
 
It may seem strange to move from describing the outcome to describing whether residual confounding 
is an issue. Normally, one would raise the possibility of residual confounding in the discussion, after 
the analysis has been completed. This is what was done in the two abstracts submitted from this 
analysis and in the first draft of the paper. In these it was mentioned “residual confounding by age is 
possible in our analysis”. The reason residual confounding may have been a possibility was that 
having low GFR was associated with increasing age, having low SES is also associated with 
increasing age and in the analysis age has been grouped into ten year age bands. So within these ten 
year bands the effect of age may still be confounding the association between SES and CKD. It was 
only after the abstracts were submitted and the draft paper written that I began to think about how to 
investigate whether residual confounding was a problem and how it could be dealt with. 
 
One of the ways of tackling the problem of residual confounding would be to classify age into 
narrower age bands, for example using five year age bands rather than ten year age bands. Another 
way would be to include age as a continuous variable rather than grouping it at all. I had chosen ten 
year age bands, rather than five years, to make the reporting of the results simpler (fewer categories to 
report) and also to avoid having some age categories with small numbers. I had no clinical reason for 
choosing ten year groups. I had chosen to group the ages rather than fit age as a continuous variable as 
the first option would allow greater flexibility in describing the relationship between CKD and age. 
Fitting age as a continuous variable specifies a particular relationship between age and presence of 
CKD – there is a linear relationship between the logit and age. Fitting a grouped variable age specifies 
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 no particular relationship. If there was a linear relationship between the logit and age then age could be 
fitted as a continuous variable and residual confounding would not be an issue, with the added benefit 
of a more powerful test. 
 
The method of deciding whether there is a linear relationship between the logit and a covariate is 
described by Hosmer and Lemeshow (2000). It involves fitting the logistic model with the covariate 
grouped into categories (with the smallest category as the references) and then plotting the estimated 
coefficients for these categories against the mid-point of the category (taking the coefficient for the 
smallest category to be zero). If the plotted points are approximately linear then there is a linear 
relationship between the logit and the covariate and so the covariate may be fitted as a continuous 
variable. This procedure was carried out for each of the surveys and the plots are shown for age 
grouped into 10 year age bands (figures 7, 8 and 9). The assumption of linearity appears reasonable for 
all surveys. Plots were also obtained using five year age bands rather than ten years bands. Also, 
separate plots were created for each ethnic group in the NHANES survey as the logistic regression 
modelling was carried out stratified by ethnic group (not shown). In all cases the linearity assumption 
appeared reasonable. Age was then fitted as a continuous variable. 
 
Figure 7: Estimated coefficients for each age group plotted against mid-point of the age group to 
determine the functional form of age in the logistic model using NHANES data 
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 Figure 8: Estimated coefficients for each age group plotted against mid-point of the age group to 
determine the functional form of age in the logistic model using InterAsia  data 
 
InterAsia: Examination of assumption of linearity in logit
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Figure 9: Estimated coefficients for each age group plotted against mid-point of the age group to 
determine the functional form of age in the logistic model using AusDiab data 
AusDiab: Examination of assumption of linearity of logit
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Table 3 shows the odds ratios for each of the SES factors when age is treated as continuous and when 
age is grouped into ten year age groups. From the tables there is evidence of residual confounding 
when age is analysed in groups as most of the estimated odds ratios are slightly closer to 1 when age is 
treated as a continuous variable. Although adjusting for age as a continuous variable had little effect 
on the overall results, it would be better to adjust for age as a continuous variable in the draft paper in 
order to pre-empt the issue of whether there may be residual confounding. 
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Table 3: Comparison of odds ratio calculated in models where age is fitted as a 
continuous or categorical variable 
  
Age fitted as continuous Age fitted as categorical 
Survey Effect 
Odds 
Ratio 
95% Lower
Confidence 
Limit 
95% Upper 
Confidence 
Limit 
Odds 
 Ratio 
95% Lower
Confidence 
Limit 
95% Upper 
Confidence 
Limit 
NHANES Education: 
Average vs 
Greater than 
average 
1.01 0.79 1.30 1.02 0.79 1.31
 Education: less 
than average 
vs Greater than 
average 
1.31 1.00 1.71 1.33 1.02 1.73
 Income: Below 
median income 
vs Above 
median income 
1.31 0.97 1.76 1.33 0.98 1.80
 Employment 
status: Not 
employed vs 
Employed 
1.12 0.86 1.45 1.19 0.92 1.55
 Employment 
status: Retired    
vs Employed 
1.52 1.13 2.03 1.61 1.19 2.17
   
InterASIA Education: 
Average vs 
Greater than 
average 
1.35 0.96 1.90 1.32 0.97 1.79
 Education: less 
than average 
vs Greater than 
average 
1.17 0.73 1.88 1.25 0.82 1.90
 Income: Below 
median income 
vs Above 
median income 
1.07 0.80 1.42 1.06 0.80 1.40
 Employment 
status: Not 
employed vs 
Employed 
1.25 0.92 1.70 1.31 0.99 1.75
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Age fitted as continuous Age fitted as categorical 
 
Survey Effect 
Odds 
Ratio 
95% Lower
Confidence 
Limit 
95% Lower95% Upper 95% Upper 
Confidence Odds 
Limit  Ratio 
Confidence Confidence 
Limit Limit 
 Employment 
status: Retired    
vs Employed 
1.11 0.80 1.53 1.27 0.94 1.70
   
AusDiab Education: 
Average vs 
Greater than 
average 
0.70 0.52 0.95 0.69 0.52 0.92
 Education: less 
than average 
vs Greater than 
average 
1.07 0.88 1.30 1.13 0.93 1.38
 Income: Below 
median income 
vs Above 
median income 
1.29 0.91 1.83 1.35 0.98 1.85
 Employment 
status: Not 
employed vs 
Employed 
1.40 0.96 2.05 1.55 1.12 2.16
 Employment 
status: Retired    
vs Employed 
2.01 1.28 3.17 2.30 1.54 3.45
 
Coding of the SES factors 
Education 
One of the socio-economic factors that was of interest was educational status. In AusDiab there were 
five different questions asked about different aspects of educational status, InterAsia and NHANES 
included only one – “What is the highest grade or year of regular school completed?”.  This question 
was not asked in AusDiab and the closest question matching this was “What is your highest level of 
education completed?” where the Reponses were categorical rather than numerical as in NHANES. 
 
In Australia and the USA completion of high school requires 12 years of education and this is the 
norm for each country. It was decided to code educational status into three categories  
• less than 12 years, 
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 • 12 years, 
• more than 12 years of schooling 
 
Table 4 presents the percentage of people in each of the three categories for each of the three surveys. 
The split between each category for NHANES and AusDiab is very roughly one third, but for the 
InterAsia survey the percentage in the <12 years category is very high. Examining the InterAsia data it 
was found the distribution of number of years of schooling was quite different to that of NHANES and 
AusDiab. This reflects the quite different development, and current status, of the education systems in 
Thailand compared to Australia and the US. 
 
Table 4: Number of years of schooling for participants in the three surveys  
Percentage 
Survey  
NHANES InterASIA AusDiab
Number of years of schooling 
Missing 0.5 0.0 0.1
< 12 years 26.9 89.3 42.7
12 years 32.3 4.3 18.4
> 12 years 40.3 6.4 38.8
 
 
The most frequently reported number of years of schooling was 4 years in the InterAsia survey 
compared to 12 in AusDiab and NHANES. Sixty-four percent of the InterAsia study reported number 
of years of schooling as 4.  
 
The present coding of educational status may present a problem when interpreting the results for 
InterAsia. Being able to say that people would be at a decreased risk of kidney disease if they had 12 
or more years of schooling would not be useful for Thailand where only around 10% of people in this 
survey had 12 or mores years of schooling. The census conducted in Thailand in 2000 reported 
average years of schooling to be 7.2 years (National Statistical Office Thailand, 2006). An alternative 
coding scheme would be to categorise numbers of years of schooling for each of the surveys into  
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 • less than average, 
• average, 
• more than average 
 
where “average” would be that which is considered the “norm” for the country. In Australia and  the 
USA the average was taken to be 12 years of schooling, and in Thailand using the InterAsia data it 
was taken to be 4 years of schooling. This resulted in the following groupings – 
 
Table 5: Number of years of schooling (recoded) for participants in the three surveys 
Percentage 
Survey  
NHANES InterASIA AusDiab
Number of years of schooling 
Missing 0.5 0.0 0.1
Less than average 26.9 11.5 42.7
Average 32.3 63.7 18.4
Greater than average 40.3 24.8 38.8
 
Two of my co-authors suggested that it would be useful to model the absolute effect of education 
status across the surveys rather than the relative effect within each survey as was chosen. One problem 
with this proposal is that it would require some way of equating one year of schooling across the three 
surveys. To estimate the absolute effect of 1 (or ten years) or schooling across the surveys would 
require a method for converting one year of Thai or Australian education into one year of US 
education. This would not be feasible and would not be investigated further. 
 
 
Total household income 
The SES factor total household income was recorded in a variety of ways in the three surveys. In the 
AusDiab study income was recorded as one of seven categories, NHANES had 28 categories and 
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 InterAsia recorded the actual income. This means that how income was analysed would be constrained 
by the seven categories available in the AusDiab study if we are to make the results comparable. 
 
It was decided that the simplest approach would be to assign the respondents in each survey to above 
and below the median household income for their survey. Consideration was given as to whether the 
median should be derived from official sources (eg census). However as in this analysis the population 
in each survey has been limited to those aged 35 and over the median from the census which would 
include all ages may not be applicable. As each of the three surveys was nationally representative the 
median calculated from within the survey should provide a reasonable estimate of the median 
household income for the population 35 and over. 
 
After this decision was made to code income into above or below the median income, as derived from 
each survey, some of the authors of the paper suggested that we might be losing important detail not 
splitting income into smaller groups and also by using a relative measure of income rather than an 
absolute one. In response to this suggestion I sent the following reply –  
 
We are constrained by how we can analyse income by the availability of data. This means if we are to 
use the same groupings, and hence, absolute measures we are constrained by the coarseness of 
recording in the AusDiab study.  
 
In order to make the incomes comparable across the three surveys we also have to convert to the 
common currency of international dollars. This involved using the World Development Indicators 
conversion factors for 2002 (World Bank, 2004) to convert each country’s currency to international 
dollars and increasing the US figure by a factor of 1.264 to account for inflation (the inflation from 
1991 to 2000 in the US - (U.S. Department of Labor, Bureau of Labor Statistics, 2006) as the 
NHANES survey was carried out in 1988-94 whereas AusDiab was conducted in 1999-2000 and 
InterAsia 2000-2001. 
 
Table 6 converts the seven AusDiab categories to international dollars and show the percentage of 
people from each survey in each category. Using these would result in a loss of detail in the InterAsia 
and NHANES studies as AusDiab studies have more responses in the middle, whereas InterAsia and 
NHANES are skewed to the low and high incomes, respectively.  
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 Table 6: Percentage of population by household income (International$) 
Total household income (International $) NHANES InterASIA AusDiab 
<2,972 0.6% 31.4% 0.5% 
2,972 – 7,423 2.0% 36.8% 8.6% 
7,423 – 14,858 10.0% 18.7% 17.6% 
14,859 – 22,286 11.1% 5.6% 16.9% 
22,287 – 29,715 6.7% 3.3% 12.0% 
29,716 – 55,715 31.3% 2.9% 26.7% 
≥55,716  38.4% 1.3% 17.7% 
 
An alternative approach would be to split up the data into quartiles for each survey, as in table 7 (this 
is also equivalent to splitting up the surveys into quartiles using the original incomes rather than 
income in international dollars).  
 
Table 7: Percentage of population by household income (International$) - quartiles 
 Total household income (International $) Percent of population 
InterAsia <2,500 24 
 2,500 - 3,999 20 
 4,000 - 7,999 29 
 =>8,000 27 
AusDiab < 15,000 27 
 15,000 - 29,999 29 
 30,000 - 59,999 27 
 => 60,000 18 
NHANES < 22,000 24 
 22,000 - 43,999 24 
 44,000 – 59,999 21 
 => 60,000 32 
 
This new categorization of income was then analysed and the age/gender adjusted odds ratios are 
plotted in figure 11. After adjusting for age and gender there is no apparent effect of income. This is 
consistent with the result when income is categorized into below or above median income. 
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 Figure 10: Estimated adjusted odds ratios for household income (Internaltional $) 
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Figure 11: Estimated adjusted odds ratios for household income dichotomised into above or below 
median income 
Odds ratio, adjusted for age and sex,  below versus above median income
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 Employment 
Each of the surveys recorded information on the subject’s main occupation and they each recorded this 
to differing levels of detail. In InterAsia occupation was recorded as one of five categories, NHANES 
had 40 categories and the occupations recorded in AusDiab were coded to the ASCO (Australian 
Standard Classification of Occupations) classification which has 986 individual occupation categories 
(Australian Bureau of Statistics, 2997) which can be combined into nine major groups.  
 
As the lowest number of categories was in the InterAsia study the other studies’ occupation groups 
would in some way have to be mapped to these five categories. However, it was suggested that should 
we wish to examine the effect of occupation in more detail it would be useful to analyse the more 
detailed occupation categories in NHANES and AusDiab studies. In order to do this a recoding 
occupation for both studies to a common classification system would be required, and preferably to a 
system with international recognition as the surveys were carried out in separate countries. None of the 
authors of the paper had any specific knowledge regarding the classification of occupation so I sought 
the advice of Dr Tim Driscoll an expert on the analysis of occupational data. 
 
Dr Driscoll suggested I look into the use of ISCO 88 (the International Standard Classification of 
Occupations created by the International Labor Office (1990)) and also provided advice on how the 
current data could be mapped to this classification. The ISCO classification scheme turned out to be 
very similar to that of ASCO. In ISCO 88 there are 10 major groups which correspond broadly to the 
nine major groups in ASCO. The extra group in ISCO 88 is for skilled agricultural and fishery 
workers, whereas in ASCO these occupations are split between  two major groups – farm managers 
are assigned to Group 1 Managers and administrators, and skilled agricultural workers are assigned to 
Group 4 Tradespersons and related workers. 
 
Although the ISCO classification is more internationally recognised it was decided to use the ASCO 
classification scheme to code both the AusDiab and NHANES studies. The reason for this was the 
purpose of the occupation classification is to provide a measure of socioeconomic status and ASCO 
provided a better reflection of SES as evidenced by the classification of farm workers. Also, the 
ASCO categories were broadly similar to that of ISCO 88 and the AusDiab data were already coded to 
ASCO so less work would be involved in coding these data to another scheme. 
 
Table 8 provides the percentage of people in each major ASCO group for the AusDiab and NHANES 
surveys. 
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 Table 8: Percentage in ASCO group for NHANES and AusDiab 
 NHANES AusDiab
ASCO group 
0.1 1.1Missing
Managers and administrators 10.0 5.9
Professionals 9.1 14.7
Associate professionals 5.8 8.3
Tradespersons and related workers 7.5 6.3
Advanced clerical and service workers 2.0 3.1
Intermediate clerical, sales and service workers 13.8 7.9
Intermediate production and transport workers 5.8 3.2
Elementary clerical, sales and service workers 0.0 3.3
Labourers and related workers 5.7 3.2
Not employed 19.6 16.7
Retired 20.5 26.3
 
 
The nine ASCO groups were then mapped to the five occupation categories that were used in the 
InterAsia survey. However, two of the InterAsia categories – self-employed and business owner - had 
no direct equivalent in the ASCO classification. Therefore, some of the InterAsia categories were 
merged and the following classification scheme was created to be used in the analysis. 
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 Table 9: Percentage in occupation groups 
 NHANES InterASia AusDiab Total 
Employment categories (Thai grouped)
0.1 0.3 1.6 0.3 Missing
Management, business owners 10.0 3.8 5.9 8.7 
Professionals 14.9 4.3 23.0 13.6 
Worker, Farmer, Self-employed, Other 34.8 68.9 27.0 40.2 
Not employed 19.6 16.5 16.2 18.8 
Retired 20.5 6.2 26.3 18.4 
  
The odds ratios showing the association between employment and CKD, adjusted for age and gender, 
are shown in figure 12. Note that the reference employment group for all ethnic groups is Management 
and business owners, except for Mexican-Americans where the reference category is Professionals. 
There were no Mexican-Americans in the Management and business owners group who had CKD so it 
was not possible to use this as the reference category. Management and business owners has been kept 
as the reference category for the other ethnic groups for consistency with the analyses of the other SES 
factors where the highest SES category has been chosen as the reference category. 
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 Figure 12: Estimated adjusted odds ratios for employment category by ethnic group 
Employment - adjusted for age and sex
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After analysing the data using these categories it was then decided that in order to cut down on the 
number of data points reported in the submitted paper it would be better to further group employment 
categories. Three categories were decided upon – Employed, Unemployed and Retired and the effect 
on the age and gender adjusted results is shown in figure 13. The pattern of results is broadly similar 
with the major change being the narrowing of confidence intervals due to the combining of smaller 
categories. 
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 Figure 13: Estimated adjusted odds ratios for combined employment categories by ethnic group 
Employment - adjusted for age and sex
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Conclusion 
The previous analyses have set out the many issues that were considered in examining the relationship 
between socio-economic status and chronic kidney disease. Much of this work will not be included in 
any formal summary of the work for publication. The draft paper which follows reports in detail only 
the associations between the SES factors and CKD and gives brief mention to the choice of method for 
estimating GFR and the implication of residual confounding. Although it can be seen from the 
previous analysis that the work involved in substantiating these brief mentions is substantial. Also, 
there was also a lot of discussion and work involved in determining an appropriate form for the SES 
factors. This work, although for the moment not required in the draft for publication, will be 
invaluable later, if and when, we are called upon by reviewers to justify the choices we have made in 
this study. 
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Abstract 
 
The relationship between socio-economic status (SES) and chronic kidney disease (CKD) was 
examined using nationally-representative data from 3 countries (USA, Thailand and Australia).  
Individual data were obtained for participants aged 35 years or above from the NHANES III, 
InterASIA and AusDiab I studies. We examined the association between CKD prevalence (GFR <60 
ml/min/1.73 m2) and education, income, employment and area of residence (urban/rural). Household 
income below national median, below-average education, being unemployed/retired and living in rural 
settings were associated with increased odds of CKD (INSERT RESULTS).  Lower SES was 
consistently associated with higher rates of CKD across different ethnic groups, however some 
variation in effect size was observed (INSERT RESULTS).  Income, employment and education are 
associated with CKD risk, however the effects vary between different population groups and this 
requires further exploration.  Our results suggest CKD prevention and management strategies should 
take account of the higher prevalence in low-income and poorly educated groups.  
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 Introduction 
 
The results of cross-sectional and prospective studies have established a relationship between 
socioeconomic status and health indicators, including physical and mental functioning, specific 
diseases and mortality (Pappas, 1993; Lynch, 1996; Lynch, 1997; Kunst, 1998). This relationship 
takes the form of a gradient, such that increasing levels of wealth are associated with increasingly 
better health (Adler, 1994), and cannot be fully explained by differences in burden of risk factors such 
as smoking, obesity, elevated cholesterol or blood pressure (Davey Smith, 1990).  Further 
investigation of this association found specific links between socioeconomic status and cardiovascular 
morbidity and mortality (Lynch , 1996; Marmot, 1978; Von Rossum, 2000).  Since chronic kidney 
disease is part of the spectrum of chronic vascular diseases, it is possible that similar mechanisms 
behind the observed association between SES and cardiovascular disease underlie a relationship 
between SES and chronic kidney disease (CKD). There is evidence from several studies to support an 
association between SES and CKD. Most have examined the link between individual- or area-level 
SES and treated end-stage kidney disease (ESKD) (Young, 1994; Byrne, 1994; Cass, 2001). Studies 
conducted in pre-end-stage populations also support an association between SES and CKD.  (Fored, 
2005).   
 
This analysis aims to address questions concerning the association between individual-level socio-
economic factors and CKD. The two principle questions which are the subject of this analysis are: i) is 
socio-economic status (SES) associated with chronic kidney disease (CKD), and; ii) is the association 
between SES and CKD different in different ethnic groups?  We address these research questions in 
parallel across three countries, the United States, Thailand and Australia, using data from three 
independent cross-sectional population-based surveys, NHANES III (USA), InterASIA (Thailand) and 
AUSDIAB I (Australia). 
 
Understanding the relationship between socioeconomic factors and early stages of chronic kidney 
disease is of particular importance given recent recognition of the effective impact primary prevention 
and early detection can have on the development and progression of chronic kidney disease. Local and 
international health promotion, education, screening and early intervention efforts will be improved 
through detailed understanding of which groups are at particular risk and what barriers exist to their 
detection and effective treatment. 
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 Methods:  
 
Study Design and Population 
 
Individual participant data were obtained for participants aged 35 years or above from the NHANES 
III (n=10,625), InterASIA (Thailand; n=5,099) and AusDiab (n=9,852) studies who had a valid serum 
creatinine measurement. The minimum age cut-off for inclusion in the analysis was set at 35, as the 
inclusion criteria for the InterASIA study stipulated age of 35 years or above. The rate of CKD in the 
population under 35 is very low.  There were 9,098 participant in NHANES, 5,063 in InterASIA and 
9,329 in AusDiab who had valid measurements on all the variables reported. As one of the principle 
questions of this study was whether the association between SES and CKD differs between ethnic 
groups, the ethnic composition of the three study populations was considered. The NHANES III study 
over samples African Americans and Mexican Hispanics in order to look specifically at differential 
health outcomes in these two groups (insert Coresh Ref).  In our analysis we therefore looked at 
white, African, and Mexican Americans separately. Although Indigenous Australians suffer a 
disproportionately high burden of chronic and end-stage kidney disease, only 88 people in the 
AusDiab study were classified as Aboriginal and Torres Strait Islanders and therefore this study was 
not powered to look at differential outcomes in this group. Due to small numbers, the Indigenous 
Australian participants of the AusDiab I study and the 423 participants in the ‘Other’ ethnic group 
from NHANES III were not included in the logistic regression analysis to evaluate the association 
between CKD and SES amongst the different ethnic groups.  No data on ethnicity was collected as 
part of the InterAsia study. 
(WPP: see Survey Design and Methods of analysis sections for a description of the surveys and a 
discussion on why adjustment for the survey design is necessary). 
 
Outcome and Exposure Variables 
The outcome of interest for this study was cross-sectional prevalence of CKD.  Presence of CKD was 
defined as glomerular filtration rate (GFR) of less than 60 ml/min/1.73m2. or Stage 3 CKD according 
to the K/DOQI classification of chronic kidney disease (insert ref). GFR was estimated using the 
Modification of Diet in Renal Disease (MDRD) study prediction formula: 
 
Estimated GFR (ml/min/1.73 m2 -1.154) = 186.3 x (serum creatinine ) x (age-0.203)  
 
*(0.742 if female), and *(1.21 if African-American) 
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Serum creatinine results for NHANES III and InterAsia had both been standardized to the same 
central laboratory, whereas serum creatinine results from AusDiab I had not been standardized.  Data 
on urinary protein excretion was available only for NHANES III and AusDiab I, and was not collected 
as part of the InterAsia study. 
 
(WPP: see the section Comparison of two formulae to estimate GFR for a discussion on using the 
alternative Cockcroft Gault formula to estimate GFR). 
 
The socio-economic variables for which data was available from all 3 studies were education, 
household income, area of residence (urban/rural) and employment level. Data on education level was 
grouped into ‘less than average’, ‘average’ and ‘greater than average’ to reflect relative education 
standards in the United States (average=12 years), Australia (average=12 years) and Thailand 
(average=4 years).  Data for total household income was similarly grouped into below median and 
above median (US: median= USD 30,000; Australia: median= AUD 41,600; Thailand: median= 
TBHT 60,000). Employment status was coded as ‘employed, ‘unemployed’ or ‘retired’.  
(WPP: see the sections in Coding of the SES factors for discussions of the coding of education, 
income and employment). 
 
Analysis 
 
The demographic, health-related and socioeconomic descriptive statistics for each of the three studies 
were calculated, and weighted to represent the source populations.  Univariate associations were 
calculated between each of the SES variables (education, household income, employment and 
rural/urban residence) and CKD (GFR <60 ml/min/1.73m2).  The univariate associations were 
estimated for each study (combined within country) and then stratified by ethnic group.   
 
The association between SES and CKD may be confounded or mediated by a number of other 
variables. Logistic regression was used to determine whether any association between SES and CKD 
remains after adjusting for such variables. Variables considered included age, sex, hypertension, 
history of cardiovascular events (heart attack or stroke), diabetes, smoking status, obesity and 
cholesterol (total, LDL, HDL).  Obesity was defined according to waist circumference, with the cut-
offs of > 80 cm if female, > 94cm if male white or African American, > 90cm if male Asian or 
Mexican-American (ref for waist circumference).   Hypertension was defined as measured Systolic 
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 blood pressure >140 mmHg and diastolic blood pressure > 90 mmHg, if the participant is currently 
taking anti-hypertensive medication, or if a doctor has ever told the participant they had high blood 
pressure or hypertension.  Diabetes was defined as plasma glucose level > 7mmol/L, if the participant 
is taking insulin or oral glucose agents, or if a doctor has ever told participant they had diabetes, 
including gestational diabetes. The multivariate adjusted association between SES and CKD was 
estimated combined within country, and then separately by ethnic group. 
 
The analysis used logistic regression to calculate the odds ratio for each of the risk factors. The 
standard errors were adjusted for the sampling design for each survey using the appropriate clustering, 
stratification and sampling weights. The analysis was carried out in SAS v9.1 using PROC 
SURVEYLOGISTIC.  
 
Finally individual study estimates were pooled using a random effects meta-analysis model to give an 
overall estimate of the effect of SES on rates of GFR <60. Intercooled Stata 8.2 was used to implement 
the META macro to calculate the pooled odds ratios. 
 
(WPP: see the section see Survey Design and Methods of analysis sections for description of the 
design of each survey, why adjustment for the survey design is necessary and the reasons for 
pooling the results using a random effects model). 
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 Results:  
 
Characteristics of the Study Population 
 
TABLE 1: Demographic and SES characteristics of study participants 
%
Survey  
NHANES InterASIA AusDiab Total
Age group 
34.4 40.8 31.4 35.335-44 
45-54 21.8 26.6 26.6 22.9
55-64 18.3 17.2 17.4 18.1
65-74 15.7 12.7 16.2 15.2
75+ 9.7 2.6 8.5 8.5
Gender 
Male 46.5 48.7 48.6 47.0
Female 53.5 51.3 51.4 53.0
Ethnic group 
White (NHANES) 79.8 0.0 0.0 61.6
Black (NHANES) 9.3 0.0 0.0 7.2
Mexican-Amer 3.8 0.0 0.0 2.9
Other (NHANES) 7.1 0.0 0.0 5.5
Asian 0.0 100.0 0.0 16.4
White (AUSDIAB) 0.0 0.0 99.3 6.4
ATSI (AUSDIAB) 0.0 0.0 0.7 0.0
Area of Residence 
Urban 48.2 32.3 58.8 46.3
Rural 51.8 67.7 41.2 53.7
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 %
Survey  
NHANES InterASIA AusDiab Total
Number of years of schooling 
Less than average 27.1 11.9 42.8 25.6
Average 32.4 63.1 18.4 36.6
Greater than average 40.5 25.1 38.8 37.9
Total household income 
Below median income 47.5 46.5 55.7 47.9
Above median income 52.5 53.5 44.3 52.1
Employment status 
Employed 59.9 77.1 57.0 62.5
Not employed 19.6 16.4 16.4 18.8
Retired 20.5 6.5 26.6 18.6
 
Demographic and socioeconomic characteristics of the NHANES III, InterASIA and AusDiab 
populations are given in Table 1. After restricting the 3 study populations to participants aged 35 years 
and above, the population of the InterASIA survey was younger than that of NHANES III and 
AusDiab.  Table 2 summarises the relevant health characteristics of the study populations.  The 
prevalence of CKD (GFR <60 ml/min/1.73m2) was 6.6% in NHANES III, 13.9% in InterAsia and 
10.0% in AusDiab. The InterASIA population had notably lower rates of hypertension and 
cardiovascular problems and NHANES had higher rates of obesity.  After stratifying the NHANES 
population by ethnicity (data not shown), African- and Mexican-Americans were younger and had 
lower socio-economic status than Whites. In terms of health status, Whites had consistently better 
health than African-Americans. However, Mexican-Americans fared worst in terms of diabetes and 
obesity measures but best in terms of smoking, hypertension and cardiovascular measures.  The 
prevalence of CKD in the NHANES III population stratified for ethnicity was 7.2% among Whites, 
5.6% among African-Americans and 2.1% among Mexican-Americans. 
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 Table 2: Health status characteristics of study participants 
%
Survey  
NHANES InterASIA AusDiab Total
CKD 
=>60 93.4 86.1 90.0 92.0
<60 6.6 13.9 10.0 8.0
Smoking status 
Current smoker 24.3 24.8 14.6 23.8
Ex-smoker 32.7 13.9 29.3 29.4
Never smoked 42.9 61.3 56.1 46.8
Hypertension 
Yes 41.2 24.3 43.2 38.6
No 58.8 75.7 56.8 61.4
Stroke or heart attack 
Yes 7.3 0.8 6.4 6.2
No 92.7 99.2 93.6 93.8
Diabetes 
Yes 10.6 9.8 7.4 10.3
No 89.4 90.4 92.6 89.7
Obese (using waist circumference) 
Yes 69.4 37.8 32.0 61.6
No 30.6 62.2 68.0 38.4
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 Results of Univariate Analysis 
 
Results of univariate analysis are shown in Table 3. Within each ethnic group all factors were 
associated with presence of CKD (p<0.05) with the exception of gender, area of residence, obesity 
amongst African and Mexican Americans and education amongst Mexican Americans. All univariate 
associations were in the expected direction except for smoking status – people who had never smoked 
or were ex-smokers were more likely to have CKD than current smokers. However, this association is 
due to current smokers being younger than non- or ex-smokers across all surveys and the association 
becomes non-significant after adjusting for age. 
 
Table 3: Crude odds ratios (95% confidence interval) for the association between CKD 
prevalence and possible risk factors 
Ethnic Group 
White 
(NHANES 
III) 
 African 
American 
Mexican 
American 
White 
Asian 
 (AusDiab II) 
Income       
 Above median 1.00 1.00 1.00 1.00 1.00 
3.45 3.46 2.12 1.50 6.03 
Below median  
(2.54, 4.69) (1.92, 6.24) (1.13, 3.95) (1.08, 2.08) (4.43, 8.20) 
      Education 
Greater than 
average 
1.00  1.00 1.00 1.00 1.00  
1.29 1.79 2.43 2.55 0.97 
Average  
(0.99, 1.68) (1.04, 3.08) (0.63, 9.29) (1.75, 3.72) (0.76, 1.23) 
Less than 
average 
3.18 4.97 2.37 5.90 2.69 
 
(2.41, 4.20) (2.94, 8.38) (0.73, 7.68) (3.79, 9.19) (2.20, 3.28) 
      Area of  
Urban 1.00 1.00 1.00 1.00 1.00 Residence 
1.12 1.36 1.37 1.31 1.43 
Rural  
(0.86, 1.46) (0.96, 1.93) (0.64, 2.91) (0.76, 2.25) (0.86, 2.38) 
      Employment  
Employed 1.00 1.00 1.00 1.00 1.00 status 
3.54 4.72 10.12 3.38 4.51 
Not employed  
(2.52, 4.98) (2.73, 8.18) (3.66, 27.99) (2.46, 4.64) (3.02, 6.72) 
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 10.01 11.10 40.72 
5.74 14.34 
 Retired (7.55, 
13.27) 
(6.88, 
17.91) 
(16.23, 
102.13) 
(3.94, 8.36) (10.52, 19.54) 
Age 35-44 1.00 1.00 1.00 1.00 1.00 
1.50 1.96 - 4.14 6.85 
 45-54 
(0.56, 4.02) (0.79, 4.82) (2.47, 6.94) (4.86, 12.15) 
4.02 8.07 8.10 14.11 13.26 
 55-64 (1.77, 9.14) (3.81, 
17.09) 
(2.81, 23.38) (8.35, 23.83) (7.49, 23.46) 
12.05 18.70 17.41 34.08 59.66 
 65-74 (5.75, 
25.22) 
(9.64, 
36.27) 
(6.71, 45.20) (19.48, 59.62) (34.27, 103.86) 
46.01 38.51 41.93 48.95 121.15 
 ≥ 75 (22.16, 
95.51) 
19.38, 
76.52) 
(16.79, 
104.73) 
(24.84, 96.46) (69.83, 210.20) 
Sex  Male 1.00 1.00 1.00 1.00 1.00 
1.58 1.31 0.99 1.34 2.32 
 Female 
(1.20, 2.05) (0.90, 1.92) (0.57, 1.71) (0.87, 2.06) (1.75, 3.07) 
Smoking status Current smoker 1.00 1.00 1.00 1.00 1.00 
2.97 2.34 3.39 1.85 2.65 
 Ex-smoker 
(2.11, 4.18) (1.48, 3.72) 1.31, 8.75) (1.29, 2.66) (1.71, 4.11) 
2.57 1.83 1.98 1.68 2.51 
 Never smoked (1.83, 3.61) (1.16, 2.88) (0.96, 4.08) 1.05, 2.70) (1.62, 3.90) 
    
Hypertension No 1.00 1.00 1.00 1.00 1.00 
7.94 
4.85 6.09 2.74 3.62 
 Yes (5.35, 
11.79) 
(3.79, 6.20) (3.21, 11.58) (2.05, 3.66) (3.01,4.35) 
Stroke or heart 
attack 
1.00 1.00 1.00 1.00 
1.00 No 
5.65 5.38 5.38 3.16 4.71 
 Yes 
(4.42, 7.22) (3.62, 7.99) (2.90, 9.99) (1.47, 6.80) (3.43, 6.47) 
Diabetes No 1.00 1.00 1.00 1.00 1.00 
3.26 4.71 2.99 1.97 1.49 
 Yes 
(2.30, 4.62) (2.87, 7.73) (2.33, 3.85) (1.13, 3.41) (1.16, 1.90) 
75 
 Obese (waist 
circumference) 
1.00 1.00 1.00 1.00 
No 1.00 
2.06 1.43 1.48 1.49 2.27 
 Yes 
(1.53, 2.79) (0.91, 2.25) (0.72, 3.06) (0.72, 3.06) (1.68, 3.07) 
 
 
Income group, employment group, and level of education were all significantly associated with CKD 
(p<0.01). Having a household income below the national median was associated with a significantly 
increased rate of GFR <60 across all ethnic groups (Aus White OR=6.03; US White OR =3.45, 
African American OR=3.46, Mexican American OR=2.12, Asian OR=1.50).  Similarly, decreasing 
levels of education were associated with higher rates of CKD for all ethnic groups except for Mexican 
Americans. Being unemployed or retired was associated with higher rates of CKD across all ethnic 
groups. 
 
Adjusting for age, gender and other known risk factors for CKD 
After adjusting for the age and gender of participants the odds ratios for each of the socioeconomic 
factors reduced. Amongst Asians none of the socio-economic factors remained associated with the 
prevalence of CKD (p>0.1). Employment status remained associated with CKD for each of the other 
ethnic groups (p<0.01), as did education (p<0.05), with the exception of amongst Mexican Americans.  
The odds ratios for income were greater than one for all the ethnic groups however their confidence 
intervals also contained one. 
 
The effects of adjusting for other known risk factors  (presence of diabetes, hypertension, CHD, 
obesity and smoking status) are shown in the last three columns of table 4. The impact on the odds 
ratios of each of these adjustments is much less than the adjustment for age and gender. As more 
factors are adjusted for the relationship between SES factors and CKD lessened. After adjusting for all 
confounders the only clear associations that remained were those for the effect of employment status 
for African and Mexican Americans and for the Whites in AusDiab. 
 
76 
 Table 4: Odds ratios adjusted for other factors 
  Crude OR adjusted for 
age and sex 
 +  + 
hypertensio
n 
+ other 
confounders diabetes 
Ethnic group Effect Model 1 Model 2 Model 3 Model 4 Model 5 
White 
(NHANES) 
Education: Average vs 
Greater than average 
1.29 0.99 0.97 0.94 1.00 
(0.99,1.68) (0.75,1.29) (0.74,1.27) (0.72,1.24) (0.76,1.30) 
  Education: Less than 
average vs Greater than 
average 
3.18 1.33 1.30 1.28 1.34 
(2.41,4.20) (1.01,1.76) (0.98,1.71) (0.97,1.70) (1.01,1.77) 
  Income: Below median 
income vs Above 
median income 
1.79 1.63 1.58 1.48 1.31 
(1.04,3.08) (0.95,2.81) (0.91,2.73) (0.87,2.54) (0.75,2.30) 
  Employment: Not 
employed vs Employed 
4.97 2.07 1.98 1.82 1.79 
(2.94,8.38) (1.17,3.68) (1.08,3.63) (1.00,3.34) (0.92,3.47) 
  Employment: Retired vs 
Employed 
2.43 1.86 2.01 1.97 3.52 
(0.63,9.29) (0.47,7.31) (0.49,8.31) (0.48,8.05) (0.86,14.44) 
African-
American 
Education: Average vs 
Greater than average 
2.37 0.86 0.79 0.79 1.40 
(0.73,7.68) (0.25,2.96) (0.23,2.73) (0.24,2.68) (0.40,4.81) 
  Education: Less than 
average vs Greater than 
average 
2.55 1.35 1.38 1.43 1.31 
(1.75,3.72) (0.96,1.90) (0.97,1.96) (1.01,2.04) (0.92,1.85) 
  Income: Below median 
income vs Above 
median income 
5.90 1.17 1.20 1.22 1.11 
(3.79,9.19) (0.73,1.88) (0.75,1.92) (0.77,1.93) (0.70,1.76) 
  Employment: Not 
employed vs Employed 
0.97 0.70 0.70 0.70 0.72 
(0.76,1.23) (0.52,0.95) (0.52,0.95) (0.52,0.94) (0.53,0.99) 
  Employment: Retired vs 
Employed 
2.69 1.07 1.07 1.07 1.01 
(2.20,3.28) (0.88,1.30) (0.88,1.30) (0.88,1.29) (0.80,1.28) 
Mexican-
American 
Education: Average vs 
Greater than average 
3.45 1.28 1.25 1.24 1.29 
(2.54,4.69) (0.92,1.78) (0.90,1.73) (0.89,1.72) (0.89,1.86) 
  Education: Less than 
average vs Greater than 
average 
3.46 1.79 1.67 1.53 1.65 
(1.92,6.24) (1.00,3.23) (0.91,3.04) (0.85,2.76) (0.86,3.16) 
  Income: Below median 
income vs Above 
median income 
2.12 1.20 1.12 1.13 1.11 
(1.13,3.95) (0.66,2.18) (0.61,2.07) (0.63,2.04) (0.55,2.24) 
  Employment: Not 
employed vs Employed 
1.50 1.07 1.07 1.11 1.06 
(1.08,2.08) (0.80,1.42) (0.80,1.44) (0.84,1.49) (0.79,1.42) 
  Employment: Retired vs 
Employed 
6.03 1.30 1.30 1.27 1.21 
(4.43,8.20) (0.91,1.85) (0.92,1.85) (0.90,1.79) (0.80,1.82) 
Asian Education: Average vs 
Greater than average 
3.54 1.00 0.98 0.95 0.81 
(2.52,4.98) (0.73,1.38) (0.71,1.34) (0.69,1.30) (0.57,1.16) 
  Education: Less than 
average vs Greater than 
average 
10.01 1.42 1.36 1.33 1.18 
(7.55,13.27) (1.05,1.92) (1.02,1.82) (0.99,1.77) (0.86,1.61) 
  Income: Below median 
income vs Above 
median income 
4.72 2.89 2.73 2.47 2.38 
(2.73,8.18) (1.53,5.46) (1.42,5.27) (1.30,4.71) (1.24,4.58) 
  Employment: Not 
employed vs Employed 
11.10 2.47 2.23 1.98 1.87 
(6.88,17.91) (1.33,4.58) (1.18,4.22) (1.06,3.68) (0.97,3.58) 
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   Employment: Retired vs 
Employed 
5.52 
10.12 6.62 5.85 (1.51,20.15
) 
4.49 
(3.66,27.99) (1.94,22.64) (1.64,20.81) (1.15,17.55) 
White 
(AUSDIAB) 
Education: Average vs 
Greater than average 
6.98 
40.72 7.65 7.24 (2.21,22.02
) 
6.54 
(16.23,102.1) (2.57,22.76) (2.37,22.16) (1.93,22.13) 
  Education: Less than 
average vs Greater than 
average 
3.38 1.25 1.20 1.20 1.27 
(2.46,4.64) (0.92,1.70) (0.88,1.64) (0.88,1.63) (0.92,1.77) 
  Income: Below median 
income vs Above 
median income 
5.74 1.11 1.03 0.96 1.00 
(3.94,8.36) (0.80,1.53) (0.74,1.42) (0.69,1.35) (0.74,1.36) 
  Employment: Not 
employed vs Employed 
4.51 1.38 1.38 1.35 1.26 
(3.02,6.72) (0.94,2.02) (0.93,2.05) (0.91,1.99) (0.88,1.83) 
  Employment: Retired vs 
Employed 
14.34 2.01 2.01 1.97 1.95 
(10.52,19.54) (1.28,3.16) (1.28,3.15) (1.27,3.05) (1.26,3.01) 
 
 
 
Pooled Results 
 
The age and gender adjusted odds ratios for the three surveys were pooled using a random effects 
model and are displayed in the forest plot below. The pooled results show that lower SES as measured 
by each of the three factors is associated with an increased prevalence of CKD. 
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 1.23              1.03-1.46     p=0.021Combined
NHANES
InterASIA
AusDiab
NHANES
InterASIA
AusDiab
Combined
NHANES
AusDiab
Combined
NHANES
InterASIA
AusDiab
InterASIA
Retired (vs. employed)
Unemployed (vs. employed)
Total years of education below national 
average (vs. average & above average)
Household income below national median 
(vs. above)
1 2
Combined
Odds ratio          95% CI
(age- & sex- adj)
0.5
1.33              0.98-1.80
1.06              0.80-1.40
1.35              0.98-1.85
1.32              1.08-1.61
0.98              0.72-1.34
1.29              1.07-1.55
1.23              1.06-1.43     p=0.006
1.19              0.92-1.54
1.55              1.12-2.15
1.32              1.11-1.55     p=0.001
1.61              1.19-2.17
1.27              0.94-1.71
2.30              1.54-3.44
1.31              0.99-1.74
1.64              1.20-2.24     p=0.002
3
Unemployed & retired vs. employed
 
Figure 1: Forest plots of meta-analyses combining results from the three individual studies.  Effect 
estimates are adjusted for age and sex.  Pooled (combined) estimates are based on random-effects 
model. 
 
Discussion 
 
Our results are consistent with the findings from other studies of the relationship between SES and 
pre-end-stage CKD A Swedish case-control study of CKD (serum creatinine permanently in excess of 
300umol/l in men and 250umol/l in women) in 18-74 year-olds found the risk of CKD was increased 
two-fold in households of unskilled workers only compared with households containing at least one 
professional, result adjusted for age, sex, BMI, smoking, alcohol or analgesic intake (Fored, 2003). 
The same study found that 9 years or less of schooling was associated with a 30% higher risk of CKD 
than 13 years or more.  A US-based prospective study of the effect of area-level SES on progressive 
CKD found that amongst white men aged 45-64, living in the lowest quartile area for SES was 
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 associated with more than twice the risk for progressive CKD compared to living in the highest 
quartile (Merkin, 2005). This trend also applied to African American women, but not to white women 
or African American men, a result implying a differential effect of area-level SES on progressive CKD 
according to race and sex, although possibly biased by the sampling frame. 
 
Incidence of ESKD varies widely according to ethnicity (USRDS Annual Report and ANZDATA 
annual report), while SES tends to be lower in ethnic minorities and marginalized groups. Persons 
with CKD coming from disadvantaged ethnic groups may be less likely to see doctors, specialists or 
receive adequate treatment, and therefore experience higher rates of unfavourable disease outcomes. 
However, studies of the role of SES in the relationship between ethnicity and ESKD amongst African 
Americans suggest SES factors explain only part of the observed excess ESKD risk, and that other 
factors must be involved (Perneger, 1995; Byrne, 1994). Moreover, the extent of the effect SES has on 
ESKD incidence has been shown to differ among white compared to African Americans, perhaps 
because African Americans do not experience the kidney-protective benefits of higher SES (Byrne, 
1994).  This is likely to relate to issues such as health care access, levels of insurance and other 
unconsidered risks such as environmental or genetic factors.   
 
In our analysis, we therefore anticipated that ethnicity may be an effect-modifier.  When we looked at 
the different ethnic groups in our study populations separately for the NHANES study there seems to 
be evidence, based on our analysis, that the association between SES & CKD is less powerful among 
Mexican Americans than other US ethnic groups. 
Care needs to be taken in attributing the difference observed between InterAsia and the other surveys 
to the ethnic composition of the Thai population. The differences may in fact be caused by other 
factors specific to the Thai population, rather than their ethnicity. 
 
Possible mechanisms behind these observations: 
 
Several explanations for the association between SES and health have been put forward. The authors 
of the Whitehall study suggest the association between employment category and coronary and other 
diseases observed during their study is mediated by factors including deprivation in infancy and 
childhood, diet and nutrient intake, fewer leisure-time activities, lack of social support, housing and 
monetary difficulties as well as psychological characteristics such as lack of control over one’s 
working life, numerous recent stressful life events and hostile behaviour. (Marmot MG, 1991). 
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 Also See: 
*Fored NDT 2003 
*Cass Health and Place 2003 – urban disadvantage and delayed referral. 
 
Limitations of our analysis: 
 
Our data is cross-sectional and therefore comes with the inherent limitations of trying to draw 
conclusions about where individuals fit within the socioeconomic structure of society based on 
measures taken at a single time point, and representing only a selection of factors by which SES may 
be assessed. Household income and employment almost certainly change across the life course.  Urban 
or rural area of residence may also change, although in our study population of adults over 35 reported 
level of education is likely to remain constant across the life course. 
In our analysis we have only considered the impact of individual-level socioeconomic factors on 
kidney health, and therefore not accounted for context and the possibility that living in a poorer area 
exerts an independent effect on health. 
 
It is hypothesized that the socioeconomic gradient in health is not simply the result of absolute 
material standards, but that there is an effect of relative deprivation mediated by psychosocial 
pathways (Marmot, 2001).  In our analysis we constructed income and education as categorical 
variables, with income grouped into below and above median, and education grouped into ‘less than 
average’, ‘average’ and ‘greater than average’ for each country respectively. Our definition of these 
variables takes into account to some extent the potential significance of socioeconomic inequalities. 
 
There is some danger of reverse causality, whereby poor physical and mental functioning as a result of 
CKD, particularly in its advanced stages, limit overall prospects for employment and income. 
The results of this analysis are consistent with previously reported findings that individual-level SES 
or living in a low SES area is associated with CKD and ESKD (Merkin, 2005).  *What does this study 
add? – looks at this question in a developed country and among more ethnic groups than previously 
reported.* Understanding the relationship between socio-economic status and CKD is important, not 
only because it identifies a sector of the community at elevated risk of CKD, but also because of its 
implications for prevention of CKD and ESKD. Individual-level SES is strongly associated with 
health care access, health insurance status, diet and numerous other factors which need to be 
considered in programs attempting addressing the burden of CKD around the world.  
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 This is the largest analysis of the relationship between individual-level SES and CKD, and the first to 
look comparatively across a number of countries using nationally-representative data.  Income, 
employment and education are associated with CKD risk, however the effects vary between different 
population groups and this requires further exploration.  Our results suggest CKD prevention and 
management strategies should take account of the higher prevalence in low-income and poorly 
educated groups.  
 
“Without understanding the social conditions that expose people to individually-based risk factors, 
interventions will fail more often than they should. This will occur because interventions will be 
targeted to behaviours that are resistant to change for unrecognized reasons…” “…some social 
conditions are fundamental causes of disease and as such cannot be effectively addressed by 
readjusting the individually-based mechanisms that appear to link them to disease in a given 
context…policymakers should require that all interventions seeking to change individual risk profiles 
contain an analysis of factors that put people at risk of risks. This will avoid the enactment of 
interventions aimed at changing behaviours that are powerfully influenced by factors left untouched 
by the intervention.” (Link BG, 1995)  
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